RELIEF FOUNDATION
Cjimcal Sciences Centre
u￿VerS1ty Hospital ￿lltree
Lower Lane
Liverpool
19 7AL
Established as a Charitable Incorporaled Organisalion
on I rh March 2014
Originally Eslabli.Ih¢d under a Deed of Trust
Daied 31Y March 1979
Annual Report and Accounts
th
For year ended 5 April 2026
Registered Charity No.1156227

CONTENTS
Management and Committees
Legal and Administrative information
Report of the Trustees
Pain Relief Foundation Aims and PoliGies
Chronic Pain
10
Resgarch and the Institute
11to12
Rese8rch Accommodation
12
Man8gem8nÉ Strnclure & Govemanc8
13
Risk Management & 8ssessment
Trustee Recruitment
14
Advisory Sub-committees
15
Grant Making & Policies
16
Public Benefit
17
Powers of Investment & Investment Policy
18
ReseN8S
19
Fundraising Regul8tor & our fundraising promise
20
Donation Policy
21to22
St8t8ment of Trustee Responsibilities
23
Clinical Section & Educ8tion
24to26
Research Reports
26to29
Auditorfs Report
30to32
statement of Financial Activities
33
Balance Sheet
34to35
Cash Flow Statement
35to36
Notes forming part of the Financial Statements
37to44
Detailed statement of Financial Activities
451046

PATROTrIS
Dame Lorna EF Muirhead, DCVO, DBE, GStJ, FROG
Mr. R. N. S. Bigland
TRUSTEES
Mr. D. Cain, FRSA, FIOD, MHSM, DipHSM, (Chairman)
Professor Michelle Briggs PhD RGN
Miss J Daley, LLB (Hons)
Professor P. Eldridge, MA, Mchir, FRCS
Mr. P. Fell, MA (Cant8b), FRSA (Deputy Chairman/treasurer)
Professor Francis MGGlone BSC (Hons), PhD
Dr. T Nash. MB, BS, Dobst RCOG, FRCA, FFPMRCA
Mr. M. Sharma, MBBS, MD, FRCA, MS¢, FFPMRCA
Ms G Thompson Msc Dip AHCS MIMI
Dr. J. C. Wells, MB, ChB, LRCP, MRCS, LMGC, SRCA, SIPP
Dr. J. R. Wiles, MBBS, FRCA, FFPMRCA (rgsigned 21/05r2026)
CHARITY MANAGER
DArs J William8
SCIENTIFIC SUB-COMMITTEE
Dr U Allam, BS¢, MPHe, MRCP(UK)(London), PhD
Dr Jamie Burgess, PhD
Miss. A. Bradshaw
ProfJ Campbell PhD Msc Bsc CSt8t CPhys FRCOT FRS8
Dr. hl. Goodson, FRCP, PhD
Dr K Heron, MSG, PhD, DClinPsyGh
Dr Selina Johnson, PhD
DrA Marshall MB Ch8, Bsc, FRCP, PhD
Dr Anne M8rshall PhD
Professor Francis McGlone ESC (Hons), PhD
MrH Neiland
Miss. C. Staunton PhD (Chair)
EDUCATION SUB-COMMrtTEE
Ms Alison Bradshaw
Dr R. J. BerwiGk MBBS FRCA FFPMRCA
Dr M Gupta MBBS, FRCA, FFPMRCA
Dr K M8tthews, Consultant Clinical Psychologist
Dr K. Pushparaj MBBS, MD. FFPMRCA
Dr. M. Sharma, MBBS, FRCA, MD, FFPMRCA, Msc ( Chair)
Mr. John letlow
Dr. J. C. Wells, MB, ChB, LMCC, FRCA

REGISTERED OFFICE
Clinical Sciences Centre
University Hospital Aintree
Lower Lane
Liverpool
L9 7AL
BAIYKERS
H.S.B.C. p.l.c.
99 -101 Lord Street,
Liverpool,
Merseyside.
L2 6PG
AUDITOR
BTMR Limited,
Statutory Auditor
Century Buildings
14 St Mary's Parsonage
Manchester.
M3 2DF
SOLICITORS
John Roberts,
Abensons Solicitors
102 Allerton Road,
Liverpool,
Merseyside.
L182DG
INVESTMENT ADVISORS
Rathbone Investment Management Ltd.,
Port of Liverpool Building,
Pier Head,
Liverpool,
Merseyside.
L3 1NW

TRUSTEES, REPORT 2026
l am dp.lighted lo take this DPPOrtunity as Chairman of the Pain Relief Foundation Charity to introduce to
you our Annual Report for the year ended 5th April,2026. We as a Trustee Committee are proud to
maintain our strong reputation as Academic leaders in the field of chronic pain research and to maintain
support to a wide group of Pain Specialists, Clinicians in Hospltals and Primary Care, our patients and
their families and Carers.
During the past year our team has worked hard to fijrther strengthen our research portfolio wilh our
Partners at Liverpool University and the Walton Centre NHS Trust. We recognise the support from
Professor Pder Clegg prior to his recent retirement from the University. Ourwork with the Walton Centre
continues to focus both on Academic collaboration and direct engagement in clinical activities. Having
been the founder Chief Executive at the Trust It has always been the case that this relationship is based
on sound and long-lasting professional Ilnks. Our activities extend to numerous research publications,
grant applications, and conferenca activities both in Ihe UK 8nd in Europe.
Both Professor Andreas Goebel and Dr Andy Marshall our dedicated Senior Research Fellows are
leaders in the field of research and continue to be acknowledged by thelr peers in Chronic Pain
Management
I would wish as always to recognise the tremèndous work of our Charity Manager Julie Wlllams and her
team in both managing our Charity, having a focus on ¢ommunSty 8ngagement and donations particularly
legacy giving. Thé governance and stewardship of our Charity enable us to hav8 Compliance with all
asp8Cts of Charity regulation. We have in the year maintained solid and regular Communi￿tIOnS via
social medla and via our website.
Please enjoy rèadlng our Annual Report and do nol he$it8te to contact us if you wlsh to discuss or assist
in continued ambition to be at the forefront of chronic paln research
Standlng Strong In the Fight Agaln8t Chronic Paln
In Ihe face of ongoing e¢onomic hardshlp, the Pain Relief Foundation remains steadfast In its mission
to combat chronic pain through innovative research and education for the medical communlty. With a
clear focus on flexibility and financial responsibility, the Foundation has Implemented strategic
measures to ensur8 Sustalnable operats'ons, allowing it lo contlnu8 delivering meaningful Impact even in
uncertain limes.
At the core of our mission 1$ e deep commltment to funding transformative researoh. W8 believe that
scientific discov8ry is the most powerful path to effective Irealmenls and lasting relief for mllllons living
with chronic pain. Even amid financlal pressures. we have priorilised research fundlng helping to drive
breakthroughs and advance pioneering studies that offer real optimism for the future of pain
management.
But our work extends beyond financial support, the Pain Relief Foundation is dedleated to supporting
the next generation of experts and slienglhening collaboratlon across disciplines. The organisation
actively supports emerging researchers, healthcare professionals, and champion collaborative
initiatives that accelerate progress. By fostering knowledge, we ensure that advancemenls in research
translate into better care and improved outcomes for patlants.
Chroni¢ pain persists as a widespread yet often invisible struggle. magnified by systemic healthcare
challenges and economic strain. Yet, the Foundation remains resolute. We are oonvinced that sustsined
investment in science and compassion is essenlial to alleviating suffering, reducing isolation, and
transforming lives.
As a charity, the Pain Relief Foundation relies entlrely on the generosity of irndividuals like you. Every
donation fuels critical research and brings us closer to a world where no one must face the daily burden
of chronlc pain alone. Your support doesn't just fund labs and studies it fiJels hope, drives discovery, and
changes lives.

With determination, inclusiveness. and dedication we move forward with positivty- Together, we envision
a future where people with chronic pain can thrive, living full, active, and empowered lives, unhindered
by their condition.
What is Chronlc Paln:
Pain is a universal experiénce, a built-ln alam systèm that wams us of Injury or Illn8ss and drives us to
seek care. But what happens when that alarm doesn't turn off, even after the body has healed, wh8n
pain persists far beyond ils original purrKJse. It evolves into somethlng much more serlous- chronic
pain.
Chronic pain is geneTally defined as pain that lasts for more Ihan three months, a timeframe that goes
well beyond the normal healing process for most injuries or medical conditions. Unlike acute pain,
which serves as a helpful warning signal and gradually subsides with treatment, chronic pain lingers,
often without resolution. It is not simply prolonged acute pain but a complex condition in its own right.
In fact, many expèrts now view chronic pain as a disease of the nervous system, not just a symptom.
Over time, the body's pgin signalling pathways can become overactlv8 or rewlred. causlng the brain
and neTves to continue sending pain messages even when there's no ongoing lissue damage. This
means a person can experien￿ real, often severe pain without an obvious physi¢al cause.
The origins of chronic pain ar8 diverse and not always Glear-cut. Common contributors include-
Mèdlcal Condltlons: Diseases like arthritis, fibromyalgla, neuropathy, and chronic back
disoiders are frequent ¢ulpiits.
Injuriès: While most Inlurles heal fully, some-especially those involving nerve damage-¢an
lead to long-term pain.
Surgery: Ironlcally, whlle surgery 18 often meant to relieve pain, it can sometimes result in
chronic pain, p8rticularly If nerves are aff8cted during the procedure.
Nerve Damage: Condltions such as dlabetes or shlngles can damage perlpheral neNes,
leadlng to lasting pain syndromes like diabetic neuropathy or post-herpetic neuralgia.
Unknown Causes: For many people, no clear source of pain can be identifled, making
diagnosls and treatm8nt especially challenglng.
Beyond the physlcal symptoms, chronlc pain takés a toll on mental health, sleep, relationshlps, and
overall quality of Ilfe. It's not somethlng you can simply "push through It Is a perslstent, often Invlslble
condition that requiras compasslon, compr6henslv• care, and a multldisaplinary approach.
Chronic pain 18 more than jLSSt a bad day it Is a dally rèality for mlllions. Undèrstanding11 as a complex,
mullifac@ted condition is the first step toward eff￿lIve management and improved well-being.
The Rlpplè Effect of Chronlc Paln:
Living with chronic paln Is kind of Ilke havlng an unlnvited houseguest who never leaves, It Is more than
just aches and pains,. it can quietly sneak into all area5 of life.
Dally tasks might take a little longer and once easy activities like walking, dancing, or even folding
laundry can start to feel like Olympic events and sornètimes you havè got to bow out last minute from
that social event, which is hard for you and your friends.
Emotionally, it can be a rollercoaster with anxiety and low moods, sleep might play hard to get, and
lel's not forget the financial sidè you can f8el it In your wallét thanks to doctor visits, tr8atmenls. and
maybe cutting back on work.
But even with all this, people with chronic pain are often incredibly resilient, creative problem-solvers,
masters of pacing. and pros at finding joy in small moments. It's a journey. no doubt but not withoul
moments of connection, and quiet triumph.

Finding Llght in the Journgy: Managlng Chronic Pain with Hope & Help
Living with chronic pain is no walk in the pad(, but there is the good news.. you're not alone, and there's
a whole toolbox of help waiting for you. The key is finding what works best for your unique situation.
and often that means mixlng and matching a few different approaches.
Medications like pain relievers, certain antidepressants, or even antl-S8izure drugs can sometimes take
the edge off and help you feel more like yourself. Bul popping pills isn't the whole story you also need
movement. Gentle exercises, physical therapy, and stretching can do wonders for boosting strength,
flexibility. and overall feel-good vibes.
Your brain is also p8rt of your management. Cognitive Behavloural Therapy (CBT) helps reframe the
way you relate to pain, giving you smart coping strategies and a mental edge. And don't forget the f6&1-
good stuff: acupuncture, massage, or a mellow yoga class might be just what your body is craving.
Some people even find relief through target8d treatrnents like netve blocks or injections, precision tools
for stubborn pain spots.
Relief is posslble, progress is real, and with the rlght rnix of support, you can find more comfort and
more joy every day.
Llvlng Well wlth Chronlc Paln
Living with chronic pain, yes. it's dlfficult but that doesn't mean life has to be all gloom and doom. With
the rlght support, a few smart strategies, and a small attllude adjustment, you can still enjoy the things
you love 8nd mayb8 even discover some new on8s along the way.
Think of It as working with your body instead of against it f5ndlng what helps, lettlng go of what doesn't,
and celebrating the small wins. Whether it's leaning on your healthcare team, trying gentle movernent,
or simply givlng yourself permisslon to rest guilt-free, every step counls.
Millions around th8 world Ilvlng wlth chronic pain know lust how tough il ¢an be when even the Ilttle
thlngs feel like a big deal, but the Pain Reliaf Foundation are on a mission to change that.
At the Pain Relief Found8tion 8nd the Pain Research Institute, we are all about hope, help, and
healing. We beli8ve a future with185s pain and more life is possible and we are d8t8rmined to make it
happen. Together, we are building a world where chronlc pain doesn't dictate your life. By backlng
brilliant science and Ihe passionate researchers we are investing in cutting-edge studies that don't lust
manage pain bul alm to Iransfom how it is treated, with real people at the heart of every discovery.
Thlnk of it as research that listens, cares, and reaches for breakthroughs that truly make a differen￿.
But great research needs great understanding. That's why wo're lust as excited about education as we
are about experiments because when people understand pain better, they can face It head on and with
more support. Together, we can crack one discovery and conversation at a time.
Finding better ways to relieve pain has never been more important. Mlllions of people are living with
chronic pain, and It's time we tackled thls challenge with fresh ideas and even bigger collaboration.
The Pain Relief Foundation and the Pain Research Institute are all about bringing people together
doctors, scientists, therapists, and advocates to shar8 knowledge, spark innovation, and make real
change happen. We're reaching out to healthcare professionals across the UK and around Ihe world,
giving them the training they need to provide top-notch care.
We are also building on groundbreaking research and making surè the voices of people with chronic
pain are heard. Together, we are advancing through each breakthrough one day at a time.
At the Pain Relief Foundation, we believe fighting chronic pain isn't just about science and care it is
also aboul doing the right thing with every pound we receive. Our work is only made possible by kind-
hearted donors like you, and we take that generosity seriously. We are all about responsible

fundraising and keeping things transparent, honest, and donor friendly, no pushy tactics. Just a
heartrelt'thank you. and a Glear picture of how your support helps make life better for people living with
chronic pain.
hen you give to us, you wlll always know exa¢Uy where your money is going because you deserve to
se8 the reg1, positive impact of your kindness
This commitment goes w811 beyond just asking for support. At the Foundation, we believe in making
every pound count that is why we keep a Careful eye on our spending, making sure every expense truly
supports our misslon of h8lping people living with chronic pain. And when it comes to investing, we
focus on sustainable growth so we can keep making a difference, year after year.
Transparency is al Ihe heart of everything we do, here at the Foundation we keep our financial re￿rdS
open and easy lo access. We regularly share financlal updates so donors and the public can see
exact￿ how funds are being used. Plus, we welcome outside auditors who double-check our work to
make sure everything is accurate and sustainable. Thls commitment to openness is our way of saying
and showlng how seriously wg take our responsibility as stewards of your support.
Th8 Pain Relief Foundation know5 it couldn't do what il does without the amazing generosity of ils
donors. With your continued kindness and commitment, we're able to make real strides in pain relief
research. A huge, heartfelt thank you for supportlng us, every contribulion big or small brings hope to
those in need.
In short, th8 Foundation is steadfast in Its dedication to belng a responsible and accountable
orgenisation, driven by ethical fundralslng practlces and prudent financlal management. 8y a(Jhering to
these corè princlp18s. we ensure that our r8sources are utilised effectively to advance ils mission of
alleviating human chronic pain. We remaln committed to upholding th8se standards, building trust, and
Inspiring continued support for our crucial work in improvlng the lives of Ih08e suffering from chroni
pain.
This work is made posslble thanks to our Board of Trustees, each of them volunteers their lime,
energy, and expertise to help gulde the Foundatlon. They play a key role in shaping our strategy and
keeping finances on track, and we're truly grateful for their ongoing support and dedication.
One of our blggest strengths is the dlversity of our Board. Wè'r8 lucky to have people from all kinds of
backgrounds and industries, each bringlng thelr own unique insights and experienc8 to help us move
fomard. Thls includes:
Medlcal Profesglonals: ProvSdlng Invaluable expertlse In pain management and research,
ensuring our 5nltlalives are grounded in the latest scientific advancements and best practices.
Admlnlstratlve Experts: Guiding our operational efficiency and ensuring resources are
allocated effectively to achleve our strateglc goals.
Legal Professlonals: Ensuring compliance and providing guidance on ethical considerations,
safeguarding the integrity of our operallons.
Business Leaders: Bringing strategi¢ business acumen to the table, hèlping us develop
sustainable funding models and Ma￿Mise the impact of our programs.
Working together, the Board provides comprehensive oversight to ensure that every decision is
dellberate and focused on achieving tanglble results. The Trustees malntain a rigorous system of
continual review across both scientific and administrative operations. Given the current economic
climate, our reserves are critical., consequently, we actively monltor our Reserves Policy to optimise
resource allocation, maximise ifnpact, and ensure we ulilise our asgets to their fullest potential.
A key compon8nt of our financial strategy Is the Investment Policy that govems the management of our
reserwes. The Trustees actively collaborate with the Investment Management team at Rathbones,
regularly reviewing and refining the Investment Policy to a¢hieve optimal perforniance while adhering to
ethical and responsible investment principles.

Beyond financial considerations, we recognise the critical importance of risk management. Our Risk
Assessment Policy is under constant scrutiny, ensuring that we proactively idenlify, understand. and
mitigate potentsal risks to the charity. We are committed to implementing procedural changes as
needed. This proactive approach allows us to protect our assets, safeguard our operations. and
maintain the trust of our stakeholders.
This commitment lo diligence and stewardship is the cornerstone of our sustainability, allowing us to
build a lasting legacy of support for the Causes that matter most.
Every year, our Trustees set the budget for our research grants. Once that's finalised. we open our call
for applications. We make sure to spread the word through specialist journals, our website,
ResearchResear¢h.¢om, and University and NHS bulletin$ to reach the best researchers WDrking in
chronic pain.
Once applications are received, they undargo a thorough initial assessment by our dedicated Scientlflc
Advisory Sub-committee. Chaired by Dr. Caroline Staunton, thls sul>committee plays a pivotal role in
ltte entire giant allocation process. Dr. Staunton and her team are entrusted with the vltal task of
overseeing our research work, meticulously analysing the significant volume of scientific information
submitted by applicants. The Scientific Advisory SU￿CoMMIttee provides InvaSuable guidance to th8
Trustses,. in identifying the most deserving applications for research grants, their expertise is essential in
priorilising projects with the highest potenlial impact. Th8 sub-committee ensures that each application
undergoes rigorou$ peer review of other re8earchers in th8 fièld to critically evaluate Ihe scientific merit,
f6asibi1Sty, and potsntial impact of each proposal. This process guarantees that only Ihe rnost deserving
projects are considered for funding.
We are profoundly gratgful for the extensive work carried out by the Scientific Advisory Sub-committee
throughout this lengthy and demanding process. Th81r expertise, commitment lo rigorous evaluation, and
dedication to advancing chronic paln research are invaluable to Ihe Foundation. Through their efforts,
we are confident that we are funding the most promislng research and ultimately contributing to a better
quality of life for those living with chronic pain.
A sel8Ctlon of reSea￿h reports from grants awarded by the Pain Relief Foundation c8n be found on
our w8bsite www.
ainrelieffoundation.o
.uk.
Just as importantly, wè're dèdicated to sharing thé latèst knowledge and technlques with healthcare
professlonals, helping them provide the very best care for their patients. Our research and educational
Initiatlves benefit greatly from Ihe support of the Walton Centre NHS Foundatlon Trust and its Pain
Clinic. We are proud lo work alongside one of Europe's leading pain centres, whose dedication to
patient care and innovation is second to none. We owe a speclal debt of gratitude to the Walton
Centre's patients. By volunteering their time for our trials. théy play a vital, active role In helping us
develop more effective ways to manage and treat pain.
We extend our gratitude to the patients who generously volunteer for research projects at the Walton
Centre and our partner institutions. Their participation in clinical trials reflects an inspiring commitment
to advancing medical science, fueled by the hope of securing a brighter future for everyon6 livlng with
chronic pain.
The Pain Relief Foundation is making significant strides In advancing the kno￿Sdg8 and skills of
he8lthcare professionals in the treatment and management of Chronic pain. Driven by the dedicated
"EducAlion Sub Committee., chaired by Dr. Manohar Sharma, the Foundation has successfulSy
broadened its educational activities and increased the avallabillty of high-quality courses throughout the
year.
Building on the success of recent conferences, the Foundation continues to its reputation for
providing high-calibre educational opportunities. The Education Sub-committee remains dèdicated to
curating and delivering ex*ptional programming. Their efforts are bolstered by the committed support
of committee members who actively oversee course development. Through this commitment to
accessible, high-quality training. the Foundation continues to empower healthcare professionals lo
provide more effective and compassionate patient care.

In August 2025 we facilitated the Leed5 Cadaver Workshop and Inte￿entIOnal workshop for pain
medicine Consultants and doctors in training to develop and update Iheir intervention skills. In June w8
facilitated the North England Pain Group (NEPG) meeting which was attended by pain specialists from
all overthe north of England. Underthe organisation of Dr Hemkumar Pusharaj and Dr Manoharsharma
we ran our annual workshop Cllnlcal Management of Chronlc Paln Course, a practical approach to
pain medicine. Planning is also underway for the biannual European Pain Federation EFIC Llverpool
Winter Cancer Pain School due to be held in October 2026 Other workshops are currently being drafted
to run throughout the year.
Dr Chris Wells was r8sponsible for organising this yearfs Annual Lecture and Dr Manohar Sharma was
sponsible for the Sludent Essay competition.
The student essay competition was again opened to Medical, Nursing. Occupational Therapists,
Psychology and Physiotherapy students. With the winners of each category presenting Iheir essay
at one of our educational meetings.
The work of the Foundation is a collaborative endeavour, including volunteers, staff, and external
partners. This report serves as an opportunity to shine a light on these individuals and Tecognise tle
integral role they play. First and foremost. we extend our heartfelt gratitude lo our volunteers. Their
selfless donation of time and energy is invaluable. Vvilhout Iheir dedication, we simply wouldn't be able
to impact as many lives as we do.
Our deepest gratllude also goes to our Charity Manager, Julie Williams, and her dedicated team..
Hayley Mccullough, and Jo Stephens. They are the driving forcè behlnd ovr dally operations. working
consoentiously throughout the year to ensure the $rnooth and effectlve execullon of our projects.
Financial integrity and transparency are paramount. and we are fortunate to have the expertlse of Kath
Johns and Emma Shepherd of BTMR Ltd, our Statutory Audllors. Thelr mellculous preparatlon and
auditing of our accounts guarantee a¢counlabllity and allow us lo maintain the trust of our donors and
beneficlarS@s. We appreciate thelr diligent work and commitment to upholding the high8St standards.
Flnally, we extend our thanks to Joseph McLoughlin & Ethard Kenny of Rathbones Investments. Their
expertise in managing our investment portfolio Is cruclal to ensuring the long-term financial stabllity of
the Foundation, allowing us to continue supporting our pmgrams and fvlfllllng our m5sslon for year8 10
come.
The success of our foundation is a testament to the dedication and hard work of these indlviduals.
Alms
The aims and objects of the Paln Relief Foundation, as set out in the Conslitution, are thè advancement
and promotion of all forms of medical research and in particular the relief of human pain and all painful
conditions of every type whatsoever and howsoever caused and to diswrinate Ihe results of any such
research throughout th8 world.
Pollcies to further Alms & Ob
octlves
In PuFsUan￿ of these alms and objectives, the continued policy of the Trustees is lo..
> Fund and enable ￿Search Into the causes and optimal treatmerst of human chronic pain.
> Provide and maintain a Pain Research In8ti1ute, headed by a Professor of Pain Scienc6. in
which research and education is conducted in pursuance of the charity's objectives.
> Undertake the support of the Pain Research Institute as a priority in the Pain Relief
Foundation's funding programme. However, research grants wlll also be made availablè and
awarded by open competition, for qualitative research projects carried out in other institutions.
> Support partnerships with higher education and the N.H.S directed to the understanding and
treatment of human chronic pain. In particular, lo provide long-term fijnds for the support of
a Chair in Pain Science at the University of Liverpool.

> Support the dissemination of the results of such research throughout the world.
> Promote and enable education and training for doctors and other health.
professionals on human chroni¢ pain and its trealmenls.
> Provide doctors and other health professionals with an information servic8 on chronic pain
and ils treatments, in order to improve patient care.
> Provide an information service to hurnan chronic pain sufferers and patients on chronic pain
conditions.
This policy has remained unchanged since the last annual report.
Chronic Pain Statistics
Millions of adults are livlng with 'Great Pain Shame,.
A study found that those with an ailment that affects their day-to-day existence rarely tell others
about the pain they're in. "The prevalènce of pain is huge. It dwarfs m08t other conditions.
PAIN AFFECTS US ALL
The Departrnent of Health reco9nlses chronlc pain both as a long-term conditlon in ils own rlght and as
a component of other long-term conditions.
Across the UK there are currently 14 million peopl8 living w5th chroni¢ pain.
HEALTH AND SOCIAL CARE
661/0 of people att8ndlng A & E sooklng help wilh pain had mad8 3 vlsits to a health care
professional in tho preceding weeks.
160/0 of ¢hroni¢ pain patlents feel that their chronic paln Is so bad that they sometlmes want to
dle.
WELFARE AND BENEFITS
Of the 14 milllon people living with chronic paln. 3.5 mllllon said their pain had kept thern from
their USLJal aclivilies, including work, on at least 14 days in the last 3 months.
EMPLOYMENT
The CMO report slates that 250/0 of chronlc pain patients lose thelr jobs, this contrlbutes to 42Q/o
in th6 lowest income households beSng more likely lo report chronic pain. compared with 270
in the highest.
410/0 of people who attended pain clinics report that their pain has prevented Ihern from working
and 13 % have had to reduce their hours.
SOCIETAL IMPACT
Low back pain is ranked highest out of 291 conditions ex8mined by the Global Burden of
Disease study,, ranking number 1 frjr years lost to disability worfdwide.
In fact, 5 of th8 top 12 disabling conditions globally are persistent chronic pain conditions.. low
back and neck pain, migraine, arlhritl8, 8nd other musculoskeletal conditions.
This situation underscores thè urgent ned for continued research to better understand and manage
chronic pain. The Pain Research Institute and other Foundation-funded laboralories remain committed
to addressing the many Complexitles that still surround this condition. With the Foundation's ongoing
10

support, the Instltute has established a robust academic foundation, enabling a rigorous and forward-
thinking approach to Ghronic pain research.
The Pain Research Institute
PRI
The Pain Research Institute (PRI) based within the Clinic81 Science Centre at University H08Pltal
Aintree was created to support academics and clinicians involved in chronic pain research. St provides
platform for pain r888archers across the Liverpool region, including NHS institutions and other
universilies. Research conducted within, and in collaboration with, the PRI ranges from small laboratory
experiments to large clinlcal Idals. Involving healthy volunteers and patients with pain disorders
They are located direclty adjacent to the Walton Centre NHS Foundation Trust, Liverpool. The dominating
factorfor our location here is because pain-related research prolects often need access to a large number
of patienls. The Pain Clinic has a through-put of over 4500 new patients each year and access to this
patient base is paramount for the Paln Research Institute to continue with their work. The symbioti¢work
that is carri8d out in liaison beiween Ihe Iwo units, and the expertise that hag emerged over the years,
has led to the 'Wallon Pain Clinic, becoming, and remaining, the largest and most successfiJl in Europ8.
All pallents recruited are fully informed volunteers.
Patient and Public Involvement (PPI) is a cornerstone of the Pain Research Institute {PRI). With
over a decade of experienGe in hosting r8gular PPI groups, our team works closely with patients to
ensure their Inslghts shape every stage of our chronic pain researGh.
The Pain Research Institute remains a hub of intense activity. The multidisciplinary research spans
a wide rang8 of fields within pain medicine,. all airned at identifying and treating the root causes of
chronic pain. Below, highlighled are the current ￿searCh avenues showcasing the promising work
undeway to alleviate suffering and improve the quality of life for those affected.
Pain Immunology - We fo¢us on the contribLrtion of immunoglobulin G autoantibodies in
Causing chronic pain.
Paln Management Programme8 - The Pain Research Institute works with the PMP
Department at The Walton Centre to ensure that we continually research PMP5 lo help
make them as effective as possible.
Paln Imaging- Chronic pain leads to changes in the central nervous syslem that are often
maladaptive - they make pain worse rather than lessen it. We have used functional MRI
to explore these changes in several groups of pain patients
Cllnical Trials - Most researchers in the Paln Research Institute conduct clinlcal trials.
We are engaged in both investigator-led and Industry-sponsored trials that assess
analgesic drugs and int8N8nts'ons
The Pain Research Institute has a long-standing history of excellence in the field of chronic pain. Their
commitment to advancing the understanding and treatment of pain is evidenced by a robust portfolio of
research published in prestigious medical journals and authored by their team of expert consultants.
Looking ahead, the Institute's doctots and scientists aim to pioneer new breakthroughs. with necessary
funding, these future research inltiatives promise to significantly improve the physical and psychological
well-belng of those living with chronic pain
Research Accommodation
The Trustees of th8 Pain Relief Foundation have continued with the agreed policy that whilst
continuing to retain the leasehold and ownership of the Pain Research Building in the Clinical
Sciences Centre, together with the fixtures, fittings and equipment therein, they will provide the
facility of the Institute, together with the fixtures and frttings, to the Department of NeuroSogi¢al
Science, Univer8lty of Liverpool, and to other such parties who are researching chronic pain, or who
wish to enter into collaborative research on human chronic pain.

This arrangement will ensure that research personnel supported by the Pain Relief Foundation, the
University of Liverpool, the Liverpool John Moores University, and those others who are employed
by another party but are working on chronic pain research under the auspices of the 'Pain Relief
Foundation, Professor of Pain Science, shall be contained in the same premises and wark
collaboratively. This arrangement offers a more structured and controlled working area and is
conducive to good working practices. The use of the premises does not Create a lease but shall be
treated as a Licence at Will.
All of the overhead and operating costs of Ihe Pain Research Institute premises are borne by the
Pain Relief Foundation and are allooated as part of the research grants. The foSlowlng 'modus
operandi, w8s pursued during the year as in previous years-.
> Th8 Pain Relief Foundation provided administration and research accommodation for the
research personnel, wilhin the Pain Research Institute.
>The Pain Relief Foundation provided limited secretarial assistance to the associated
research personnel, from its own employed staff.
> The Pain Relief Foundation discharged all ￿$t$ connect8d with the accommodation ofthe
Pain Research Institute and its operatlonal f8¢ilities, including overheads, heat, light,
repairs, and purchase of new equipment etc.
> Th8 Pain Relief Foundation discharged all costs connected with th6 provision of all
consumables and computer hardware for the Professor of Pain Science and all other
grant aided Researchers working in the Pain Research Institute.
> The Pain Relief Foundation dlscharg8d all costs connected with the provision of18cture
theatre and associated facllitles.
> Under the pr8senl structure, the 2 Heads of the Pain Research Institute are charged with
r8porting to the Trustees in respect of all research work carried out under the Pain Relief
Foundation grant arrangements, and also on th8 additional research that has been mad8
possible through the Foundation's fundlng and provision of accommodatlon.
This 88tablished procedure 18 an essential method to evaluat8 and measure the success and
effectiveness of the research work being conducted and to ensure that it is achieving its aims. They
also maintain a liaison with the Scientific Committee and Education Sub-committee, attending their
meetings in an Ex-officio capacity.
RESEARCH COQ)RDINATION & EDUCATION
The research co-ordination accommodalion is located in the administrative area and fulfills a range
of functions in its operational role. It supports the Pain Resear¢h Institute in several fields, providing
accurate sources of scientific and medical information to assist the researchers in many projects.
Under the direction of the Education Sub-committee, the Education Section also undertakes the
operational factors in the Conduct of all postgraduate courses that are organised throughout the
year, arranging the tea¢hing seminars, overseeing the Pain Relief Foundation Annual Lecture,
¢ollaling and ensuring the ¢orre¢t and tim8ly marking of Studenl essays and organising external
conferences.
12

STRUCTURE GOVERNANCE AND MANAGEMENT
Governlng Document On 6* April 2014, the Pain Relief Foundation was incorporated as a
Charitable Incorporated Organisation under Charity number 1156227.
Structure Gov9rnance & Mana
ement
The Pain Rellef Foundation is controlled by its Constitution as a Charitable Incorporated
Organisation managed by a Committee of Trustee5 and at their meetings the Committee regularly
conducts an assessment and review of their number, taking into account the sknll requirements of
the members in conducting the affairs of the Trust, and any potentia5 retirements in the forthcoming
12 month$. From this review, consideration is given to the need, if any, to recruit further Trustees.
In the event that further recruitment is deemed necessary, the Committee of Trustees will seek
suitable candidates through a process of personal contact across the Universities, the Health
Service and other appropriate professional bodies associated with the charity. Details of the
Trustees are shown on page two of this report.
The power to appoint a new Trustee or additional TNstees of the charity Is vested In the Committee
of Trustees and new appointments may be made by a resolution of a rneetlng ofthal Comrnitteg. A
Trustee may retire upon giving two months, notica In writlng of Intentlon to do so to aach of th8 Oth8r
Trustees. The Trust Constitution requires that the number of Trustees should not be less than three
at any time, but there is no limit on the maximum number and Trustees are not requlred to retire and
8tand for re-election.
No expenses of any type will b8 paid to any Trustee, nor wlll any Trustee be paid any remuneration
or payment of any kind from the FoundalSon In th8lr capacity as a Trustee. All the Trustees will give
free of their time and act in an honorary capacity. This is confirmed in each year's Annual Report &
Accounts.
In the period 61h April 2025 to 5th April 2026, Ihere were no expenses of any type paid to any Trustee
nor were th&re any Trustee in receipt of any remuneration or payment of any kind from th8
Foundation in their capacity as a Tru81ee. All of the Trustees gave free of thelr tlme and acted in an
honorary capacity.
The Committee of Trustees conduds four quarterly meetings each year at which they receive reports
on the acllvities and achievernenls that have occurred since the previous meeting. The meeting
agendas enGompass reports on the full range of activities and situations including day-to-day
administration, investments and reserves. cash flow and risk management.
The Committee of Trusl8es continues to review several areas of importanGe in the effective
management ofthe Foundation. The prepared 'Risk Assessment, policy is subjeGt to regular review
to ensure that potential risks to which the charity may be exposed are adequately identified,
assessed and mitigating steps taken. This operational area is considered to be of the greatest
importance, and procedural changes will be implemented if deemed appropriate.
Relatsd Parties
For the purpose of preparing accounts in accordanGe with the Statement of Recommended Practice
for charities, in the opinion of the Trustees, the following are related parties to the Pain Relief
Foundation-
The Trustees and their immediate family
The National Health Service
> The University of Liverpool
13

Risk Mana
ement
The trustees have a duty to identify and review the risks to which the charity is exposed and to
ensure appropriate controls are in place to provide reasonable assuran￿ against fraud ancl error.
Risk Assessm8nt
The Trustees have prepared a risk assessment register in which they have recorded the details and
results of an extensive study regarding the potential risks to which the charity may be exposed in
the conduct of ils alfairs. The Trustees have satisfied themselves that through the actions they have
taken, the identified risks have been reduced or eliminated, and that appropriate procedures and
controls to deal with the risks are in place, so that any resulting or potential impact that the charity
may experience is minimised.
The risk assessrnent register is subject to at least an annual review and in géneral it is an ongoing
review. SuGh reviews 8nsure that all of the procedures in place continue to be appropriate to the
conduct of the charity and that it 15 adequate in th8 light of experience. Whère appropriate, systems
or procedures have been e6tabllshed and put into plac8 so as to miligate any risks which may arise
or develop
Trustee Indemnlt Insurance
The Trustees do not contract a Trustee Group Indemnity Insurance pollcy.
Recrultment A
ointment and Inductlon of New Trustees
In selecting people to be appointed as trustees, nominations are submltted to a meetlng of the
Committee of Trustees, so that they each have the opportunity of evaluating the strengths of the
candidale(s). In considering each nominee, thé trustees take into account that person's professional
qualifications or p8rsonal qualities, Ihèlr commitment to promoting and furthering the aims of the
Foundation, and their ability to make a contribution to the effective management of Ihe Foundation.
If the nominee 18 de8med acceptable. then the appointment 1$ conducted in accordanc8 with the
established procedure of induction and training.
The Chair of th8 committee will extend an invitats'on to the candidatelsl to attend an early me8ling to
discuss the appointment in more detail. This is followed by a further meeting with the committee of
trustees at which the new trustee Is introdu¢8d, and a formal appointment confirmed. On
appointment, the new trustee is required to sign a declaration stating thatthey comply with the fomal
conditions required of a Truytee and are therefore able to legally serve as a Irustee. It is a
requirement that a declaration of interest be made so that any conflicting interest is noted and
registered accordingly. Should any interest be registered, then at any meeting wh8r8 there is such
a confliGt, the Trustee will be required to withdraw and not vote on the matter. It is also declared
that none of the Trustees have an interest in th8 phannaceutical industry. However, any such
interest would be registered.
An induction meeting is then held with the Administrator who will inform the new Trustee of their
powers and responsibilities, the operational policy, the managament arrangernents for the charity'5
investment funds and the procedure of receiving applications for research grants and how the
applications are processed through selection. Other meetings are then held with the Sub-
Committees at which their operational roles and powers are discussed.
An induction welcome pack is provided for the new Trustee, which contains a copy of the
Constitution, Copies of the Trustee Committee's meeting minutes and the meeting minutes of the
Advisory Sub-committees, each covering the past 24 months, cash flow reports for the same
periods, and copies of the previous two years, Annual Report and Accounts. A presentation folder
is prepared containing copies of the Reserves Policy. Risk Assessment, Managemenl Flow Chart,
ission Statement and Equal Opportunities Policy. In addition, a copy of the Charity Commission's
publications.
14

Education Adviso
Sub-committee
Appointed by the Committee of Trustees, this sub~committee is the driving force behind the
Foundation's educational and informational outreach, ensuring that knowledge is not only generated
but effectively disseminated lo those who need it most.
Chaired by Dr. Manohar Sharma, a distinguished Senior Pain Consultant within the N.H.S. and a
dedicated Trustee of the Foundatlon. the sub-comrnlttee exempllfies a unique blend of cllnical insight
and strategic vision. Its composition speaks volume5 aboutthe depth of expertise al its disposal, inoluding
leading Neurosurgeons, Senior Pain Cliniclans, and a Cllnical Lecturer with a Speclal Interest in Pain.
The primary rnandate of this sub-committee is to advise the Trustees on all educational issues and to
robustly develop the Pain Relief Foundation's eduGalSonal footprint. This is achieved through a mults-
faceted approach, encompassing..
> Publlcatlons: Developing and endorsing high-quality written materials.
Courses & Lectures: Designing and delivering educational programmes for health
professionals.
Llterature & Conferences: Organising and particlpatlng In forums that foster knowlèdge
exchange and collaboration.
Beyond direct educational programmes, the commitiee plays an equally crucial role in Ihe
dissemination of vital informatlon. They are specifically tasked with identifying the most appropriate
methods for publlshing and sharing..
> Su¢ces$ful Research Results: Translating complex findings into accessible formats.
New and Improved Treatment Methods: Providing updates on the latest advanc8ments in
pain care.
Information Leaflèts for Pa5n Sufforer8'. Empow8rlng patl8nts by dlrectlng them to Ihe best
treatment resources and centres.
This Information is distributed through the medical press and both the Foundation's website and the
Institute's website. All of the members act in an honorary capacity.
Sclentlflc Adv180
Sub-commltte
The committee Is responsible for advlslng the Trustees on the stratsglc allocation of funding for
research projects and grant applications. Under the leadership of Dr. Caroline Staunto
dlslinguished and formidable research associa1￿the panel benefits from expert guidance. Dr.
Staunlon's flrm, equltable approach ensures Ihal every funding decision is rigorously evaluated based
on sciènllfic merit. potential Impact, and alignment with the Foundatlon's core mission.
Her fellow committee mèmbers aré meticulously recTUlt8d for their profound and in-depth knowledge of
chronic pain condilions. Drawn from both local and external treatment cenlres, they represent the
myriad disGiplines involved in the comprehensive study and treatment of human pain. This diverse
expertt'se ensures a holistic and nuanoed evaluation of research proposals. encompassing the many
facets of pain science- from neurobiology to psychological interventions and clinical treatment
modalities. Crucially, all members dedleate thèlr time and 8xpértise In an honorary capacity
The Committee seNes as an indispensable source of information. advits. and 8xpert opinion, particularly
in its role of evaluating and prioritising the numerous funding applications for scientific research deemed
worthy of support. Their rigorous assessment process is vital in identifying projacts with the highest
potential to yield significant breakthroughs. The Committee continues to be the source of invaluab5e
information, advice and opinion when reporting on, and priorilising, th& numerous funding
applications for scientific research which were considered tD be worthy of support. 11 also continued
with the vital task of overseeing the results from the rnany facets of research work, assisting the
Trustees in interpreting, and analysing th8 large volum& of scientific infomiation submitted by
Research Fellows, Grant Holders.
15

The purpose of receiving and analysing these report$ is to satisfy the Trustees that:
The research being funded is achieving the projected resulls to a satisf8CtDry and accepted
scientific, medical and research standards.
> the research is likely to reach its stated aims.
> ethical approvals remain in place and are being followed scrupulously.
> research Governance is being obse¢ved at all times.
> quality standards are being maintained.
> the costs of the research are maintained within the grant limlts.
> the research is being managed and monitored effectively.
The head of the Pain Research Institute is ¢alled to attend each of the Trustee meetings to provlde the
Trustees with an insight into the advances and the strategic development of the research opportunities
being pursued. Reports are also received from the appointed Education Advisory Sub-committee, which
is principally involved in directing the Educational Meetings, Lectures, Student Essays aTKI Pali811t
Information issues and the Scientific Advisory Sub-commlttees which undertakes the task of advising thé
Trustees on all aspects of Research and Research Grant applicalions.
Grant Makin
Polic
> In November 8ach year, the Pain ReSlef Foundation advertises in the national médlcal press and
social media, to invite well established researchers and scientists to submlt applications for Pain
Relief Foundallon grants, to carry out research projects on human ¢hronic paln .The notice to
apply for grants Is advertised in the selected medlcal journals, on the Pain Relief Foundation
Webslte and social medla, on the NHS grantwebsite and through other appropriate media., there
Is a closing dale for the receipt of such appllcalions. The advertisement states the uppér
{monelary) Ilmlt of granls, which may vary from year lo yéar.
> On racelpt of appllcatlons, the Foundation's Charity Manager ensur8S that all appropriate
sections of the applScation forms which have been received are correclly completed and then
arranges a meeting of Ihe Scienbfic Sub-comrnittee lo presenl Ihe Abstracts of the appllcatlons
to the members. At this meeting, the members jointly select and nominate independent and best
qualified, learned medical persons who will be asked to peer revlew each selected appllcation to
go through lo round 2 and lo glve their expert opinions.
> After the meeting the Charity Manager writes to the selected peer revieweTS, submitting a copy
of the application asking if Ihey will provide an assessment of the proposed research, tha
Ilkelihood ofthe work suC￿eding and the cost effectiveness of the requested budget. In addition,
references are sought regarding the appli¢anls and tfve outGome of previous research projects
for which they have received funding from all sources, When all applications are complet8 Wlth
the peer reviews and references received, a full set of each application is submitted to each
mernber of the Scientific Advisory Sub-committee, for consideration and prioritisation in
preparation for a selection meeting of the members.
> At the grant meeting, the Chairman calls the attention of the members to the received Peer
Reviews and References which are Feferred to throughout the process of considering the most
appropriate and worthy applications deseNing of a grant. Each committee member delivers an
opinion on the applications received and scores each application bebmeen 1 and 3 with <1) being
the lowest score and (3) the highest score. These scores are then brought together with the Peer
Review seores and the applications Ilsted In order of achievement, at which point the Chairman
and the cornmittee draw recommendations to place before the next meeting of Ihe Trustee
Committee. When the Trustee Committee receives the advice of the Scientific Advisory Sub-
Committee, they decid8 which applicatlDns, if any, will be funded in accordance with advioe
received, and in the light of funds available.
> The Trustees may recommend that an application not be funded. be funded in full, or be funded
at a reduced level. In the event that the Trustees are considering a number of competing
16

recommended applications for which the Foundation's funds are inadequate to fund them all, Ihe
Trustees may invite the Chairman of the Scientific Advisory Sub-committee. together with those
members of the Sub-committee who are also Trustees, to help them prioritise the applications.
Each grant is specific to the holder and ceases should the grant holder terminate their post.
New rants a
roved since the last re
1. An applicalion is for a 3-year prize PhD Student for a lolal of £83,478 submlttèd by Prof Karen
Ersche of Unlversity of Cambridge and is titled Investigating the neurobehavioural effects of
opioid and non-opioid pain medicab'on$.
2. An application for a 12-month grant for a total of £18,787 submitted by Dr Susannah Walker
of Llverpool John Moores University and is titled.. Phy&ologlcal Synchrony in ChroniG Pain.
3. An appllcatlon for a 36-month grant for a total of £29,824 submitted by Dr J Southcombe of
University Oxford and is titled 'Understanding endometri05is associated pain,.
Publlc Bènefit
As stated, the Foundation's objectives are supported by a commitment to fostering peer-reviewed,
high-caliber research aimed at advancing patient treatment and pain management. Furthermor8,
the Foundatlon Invests in the professional development of healthcare practitloners. These activities
remain under constant oversight by the Committee of Trustees and Advisory SulFCommittees,
ensuring that our strategies remain agile and our outcomes Consistently me8t the highest
professional standards.
The development of Improved patient services and treatmenl is ¢onsider6d to be a priorlty issue by the
Foundatlon, and11 works symbiotically and in co-operatlon wlth the NHS and Unlversities lo provide post-
graduate scientific educatlon in chronic pain relief. A number of postgraduate trainlng courses have been
conducted each year, for the continuing edu¢atlon of nursés, GPS, and for cllnlcal paln specialists.
The Foundation provides 8n essenllal Informatlon s8Nice for both h8althcare professionals and patl8nts.
We equip General Practitionefs and pain specialists with the latest update5 on pain management
treatments, while offering patients, families, and carers eompr8h8nsiv8 r8sources on chronic pain. Our
webslle features a wide range of dowr¢loadable guidance and support materials, empowering indlvlduals
lo take an active, informed role in managing thelr ¢onditions.
Pain sufferers who make telephone contact with the Foundation are connected to experienced, frlendly
staff who are trained to sympathetically and professio)nally direct enquireis through to av8i18ble services
and advice centres. They are also able to guide sufferers into how they can avaS1 themselves of these
services and what actson they can take to be referred to GliniGal setvices for pain treatment.
Patients also receive direct benefit through research results which lead to the development of nèw and
improved treatments for chronic pain conditions. These results are delivered to pain treatment clinics
ng1iona51y, and indeed internalionally, Ihrough the dissemination of research informatlon by the
Foundation either electronically, from our website, in medical publications and by way of educational
meetings for health prDfessionals.
With living with chronic pain affecting approximately 40Tr/ts of the British population, it can be seen that the
work of the Foundation provides a benefit for a huge number of people. Reports on the research work
supported by the Foundation are included in later pages and give a vast amount of infomiation on the
progress that is being made with human chronic pain, and you are encouraged to read this section.
Volunteers
The Pain Relief Foundation does not receive any funding from central or local government, the health
service, or other official bodies. Instead. the FourKlation depends entirely on donations, gift 8id, legacies.
17

appeals and contributions from supportive members of the public. from generous companiès and from
several small trusts. There is a small level of direct fundraising aclivity organis&d and conducted by the
Foundation's own staff, supported by one or ￿0 volunteers, an area in which we would like to increase
our support. Additionally, it seeks to secure grants from trusts and the commercial sectorto fund speclfic
ressarch projects.
The Foundation is not in receipt of benefits in kind, either by way of services. facilities, or donations-in-
kind. It does, however, receive some Ilmited benefit from the very small number of volunteers who
support the fundraising section in the organisation and conduct of small ev8nts. The Trustees recognize
the intangible value of the contribution of volunteers lo the charity and the Trustees are of the opinion
that such income cannot be reliably ascertained. However, it is considered that such intangible income
is unlikely to be material.
Powers of Investment
The Constitution provides the Committee of Trustees With the following powers:
To administer a bank account in the name of the Foundation at such bank as the Trusteès
shall decide.
To invest in the name of the Trustees, any monies not required for the immediate purpose
of the Foundation, in such securities as they may from lime to time declde as if they wer6
beneficially entitled and whether such se¢uri118s shall be Trustee investments or not and
shall have power from time to time to transpose such investments.
That any property purchased by the Foundatlon shall be vested in the Trustees appointed
for that purpose and the Trustees shall enter into a Oeed of Trust setting forth the purposes
and conditions under which they hold the said property in trust for the Foundation and shall
with such consent as is by law required deal with the property so vested in them by way of
Sale, mortgage, charge, lease or otheNise howsoever directed by the Foundation.
Investment Pollc
The Trustees have developed an investment policy which it believes will respond to Éhe needs of
the on-going adivities of the Foundation. Sufficient funds are retained in investment that will ensure
we can respond to all contingencies as they may arise. Equally important is the strategy of investing.
The Trustees have discussed their attitude to risk and wer8 happy with the previous Attitude to Risk
Questionnaire which categorised their attitude to rlsk as a 5 on a scale of 0-6 where 6 is the highest
risk tolerance.
The objective is that thls investment policy will produce improved values and income, whilst at Ihe
same time safeguarding the short-term and long-term financial needs of the Foundation. The
Trustees seek the advice of its Investment Advisors, Rathbone Investment Management Limited
and at regular meetings with the Advisors, in-d8Pth reviews are held into the investment portfolio
that makes up the reseNe fund.
The investment decisions taken by Ihe Trustees throughout this finan¢ial year have proved to help
preserve the portfolio as much as possible in the current climate. Supported by the Advisors and
making several minor adjustments, for the best possible oulcome the fund has this year seen an
increase compared with the end of the Sast financial year. At a joint meeting with their Advisors, the
Trustees set an investment policy of 65 % of the funds invested into 'Equity Investments, with a view
of maximising the Securities and to invest 350k of the funds into 'Fixed Interest Securities,. The
decision to ease the approach with fixed interest investments was a very positive decision at the
commencement of the year.

Reserves Polic
The strategy developed by the Trustees is to hold a level of reseNes that is deemed to be
appropriate from time to time, to ensure that..
> The committed and planned research projects undertaken in the short, medium, and long
term are sustainable.
> The Trustees can address any problems that arise, including the1055 of any significant
source of income, which might restrict the ability of the Charity in carrying out its
objectives.
> Sufficiènt funds are available to respond to new and important projects that are identified.
> The Trustees can respond to a shortfall of income in any financial year, that may occur
for whatever reason. and which shall enable the research that is already authorised, to
continue without a break.
In setting the level of reserves, a conservative management style has been adopted that is
consistent with the Trustee's responsibilities who have agreed a broad spread sector exposure to
increase diversity and to regulate risk. The Trustees have established a position that the level of
unrestricted reservos and investments should be adequately sufficient to respond to the above
operallonal poli¢y and n88ds. Th8refore, the Trustees have agreed with the following..
> To provid8 r8serv8S to cover the estimated c06ts of funding existing research, research
coming on-line, overheads, research administration support, charity administration and
fundraising over three years. Based on average annual expenditure, this need is
£1,270,245
> To rotain investments, an amount that will enable the Trustees to respond to new and
important projects that may arise. In arrivlng al a level of retention, consideration has
been given to the fact that such projects may require funding for at least years and
possibly three years.
It Is considered thal in view of th8 ongoing investment market volatility and with the unsteady
present Un￿rtaIntieS worldwide, the present level of reseTve5 is adequate lo meet these criteria.
Tradin
Changes in the 2000 Finano Act, Chapter 17, allowed exemption to18x on charitable incorne from
trading activities up to predetermined levels. The Charity continues to carry out a very small level of
in¢idental trading within the prescribed Ilmits.
FR
fuliDE14lSI￿.
REGVtATOA
FUNDRAISING REGULATOR
The Pain Relief Foundation is a Member of the Fundraising Regulator (FR) and has been since its
inception in 2016, The FR is the independent regulator of charitable fundraising and was s?t up
following the Etherington review of fundraising self-regulation (2015) to strengthen th8 SySt6m of
regulation and restore public trust in fundraising.
The Fundraising Regulator IFR) is open to all fundraising organisations, suppliers, and associates.
Members commit to the highest standards of practice and uphold the Fundraising Promise.
Displaying the FR logo on all fundraising materials signals this commitment, assuring the public that
19

the organisalion follows best practices and provides a robust complaints process as a vital safety
net.
It is a requirement that a charity submits an annual report to the FR, advising the Board of the
number of complaints received by the Charity, in relation to Its Fundraising activity, by category. The
report requir8s the charity to notify the Board of action taken to resolve any such complaints and
what the outcorne results are.
Pain Relief Foundation Is pleased to report that in the year ending 5th April 2026, no complaints had
been received by the charity in the preceding 12-month period. A report to this effect was submitted
to the Board of the FR as required.
The Pain Relief Foundatlon Fundraisin Prornlse
We are always committed to working to the highest standards of practic8.
We promise donorg that we will cornply with the FR Codes of Fundraising Practice and do all that
we can to ensure that fundraisers and volunteers will at all times comply with the Codes and with
this Promise.
We comply with the law. health and safely and the environment. W8 will not put unfair pressure
on anyone to donate. Ifyou do notwantto donate, we will respect yourdecision. We require anyone
fundraising on our behalf to clearly identify themselves as one of our r8pres8ntatives.
We are honest and open and do not make false or exaggerated claims. We do what we say we
are going to do and do not pretend to do things that we cannot. We will answer any reasonable
questions you have about our fundraising activllies and costs. Please ¢ontact us for information,
vlsit our website or see our Annual Report.
We are clèar and give clear detalls about how you can make a gift. If you make a regular gift and
you want to cancel it, w& will carry out your canc&llallon instructions as soon as possible. Vve are
clear about whal we do and how your gift is used for the effective support of our beneficiaries.
We are falr and respect the rights, privacy, and dignity of each of our supporters and beneficiaries
and conform to the Data Protection Act, We will only use your personal information for the purposes
stated and for which you have given your consent. If you tell us that you do not want us to conla¢t,
you in a particular way (e.g., by telephone) w8 will not do it.
We are reasonable and responslblo and will be careful not to use any images or words Ihal cause
distress or offence. We make sure that our events are well run and meet health and safety and
environmental requirements, and we avoid causing any nuisance, damage, or disruption. We will
not use excessive emotional arguments to make you feel guilty about not giving to us.
Wo are accountable and should you be unhappy about anything we have done whlle fundraislng,
you can write to us and complain. We have 8 complaints procedur8, and we will aGknowledge your
complaint within 7 days and Commit to dealing with the matter within 30 days. A copy of our
proceduro is available on request and if we are unable to resolve your complaint, we aGcept the
authority of the FR lo rnake a final adjudication.
DONATION POLICY
This policy h8s been set out by the Trustees of the Pain Relief Foundation. It is a public guide to
how the P8in Relief Foundation makes decisions on accepting donations and the procedures they
follow. The policy is aligned with the codes of Fundraising Practice published by the Institute of
Fundraising.
20

This document makes clear the Trustees, legal obligations with the regards to the ac￿ptance and
refusal of donations. It outlines the day-to-day procedures that need to be adhered to and ensures
decisions are not taken on an ad-hoG basis but are in support of Pain Relief Foundations
strategies and objectives.
Trustees, legal obligations
The Trustees take overall legal responsibility for decisions relating to whether a donation can be
accepted or refused.
The Trustees must b8 able to demonstrate that they have acted in the best interest of the Charity.
The Trustees have a duty to ca￿fUllY, basèd on 8videnc8 made available to them, whether thè
Charities interests will be better served by accepting or refusing th8 donation and to act
accordingly.
These judgements must not promote any Trustee or employee's personal moral agenda, or
interest and the Trustees must not allow individual or colledive pèrsonal, political or ethical issues,
which are not directly related to Interests of the Charity, to affect theirJudgment.
Trust88s must not derive any personal benefit lindlvidually or ¢ollectlvelyl from donations, offered
to the Charity.
Policy
On a day-to-day basis, the Charity's board of Trustees delegates the responsiblllty lo accept or
refuse donations as follows, provicling Ihe Charity Manager is sure Ihat any potential individual or
corporate donor are supporting the charity in accordance with this policy.
> A donation must be clearly evaluated to establish whether it would be in the best interest of
the Pain Relief Foundation to accept or refuse it.
> The donation should contribute towards the Charity's overall strategy and plans.
> The Charity will not acc8pI donations from individuals or companl&s whose wealth are
known to result from illegal activities or where there are indications of corrupllon and related
crime.
> The donor's objectives or activit16s must not appear to be incompatible with the Charlty's
Vl8ion, mission, and values, particularly rf this risk is causing significant damage to the
Charity's integrity, public image, or professional reputation.
The Paln Rellef Foundatlon will refuse donations in the following clr¢umstances:
￿ere the activities of a donor are directly contrary to the objectives or agreed policies of
the Charity or the Charity suspects the gift has been donat8d to facilitate money laundering
or olher criminal activity.
ere it can be clearly shown that the cost to thè Charity of accepting Ihe donation will be
greater than the donation itself, and that the a¢¢eptan¢e of the donation will directly lead to
net decline in assets of the Charity.
Where the offer of support is dependent on the fulfilrnenl of ￿rta1ft Conditions placed upon
the Charity and any Gondition,
A) Is in itself contrary to the obj&ctives of the Charity
21

B) Is regarded as needing an unreasonable level of support from the Charity especially in
relation to the size or impacl the donation will have on the Charity's charitable aBtivities.
C) Will divert the Charity from pursuing its current objectives, policies, or work priorities as
a necessary fulfilment of the conditions alone.
The Trustees will take great care and consideration in deciding whether to accept or rofuse
a donation.
Donation Rècognition
Glft Acknowledgment & Accountablllty
> All donors will receive a porsonal thank you letter and receipt, regardless of gift amount.
> All gifts will be formally acknowledged as quickly as possible, and in any @vent wilhin S
working days.
The reporting requirements of all Grant Makers will be fulfilled thoroughly, accurately and
within their required timeframe.
> Major donors for specific projects wlll receive where réquired and appropriate regular
updates on the progress of the project.
> Where appropriate and required the families of legacy donors will receive a report on the
use of the bequeathed funds.
Recognition
Any donors expressed desire for anonymity will be strlctly adhered to
> Any public recognitlon wlll only be undertaken with the Donors &xpress permission
and in compliance with data protection legislation and best practice.
> Recognition may be tangible by way of a physlcal acknowledgment such as a plaque and
would be placed within the Pain Relief Foundation. Thi8 type of recognition would be
decided by the Trustees.
> In general costs of r8¢ognition shall not ex￿ed Syo of the gift amount.
> In all cases the cost of recognition shall be both reasonable and proportional.
rhe Charlty reserves the rlght to refuse. discontlnue or remove publ1¢ ro¢ognltlon whethertangiblo
or Intanglble, at any tlme If for any reason it considors tho 8ssoclatlon to bg damaging to Its
reputatlon. Thls course of a¢tlon wlll bo d6¢ided by tha Trustees.
STATEMENT OF TRUSTEES RESPONSIBILITIES
The Trustees are responsible for preparlng the Report of the Trustees and the financial
statements in accordance with applicable law and United Kingdom Accounting Standards
(United Kingdom Generally Accepted Accounting Practice).
The law applicable to charities in England and Wales, the Charities Act 2011, Charity
(Accounts and Reports) Regulations 2008 and the provision of the Constitution requires
the Trustees to prepare financial statements for each financial year which give a true and
fair view of the state of affairs of the charity and of the incoming resources and application
of resources, including the income and expenditure, of the charity for that period. In
preparing those financial statements. the trustees are required to.
select suitable accounting policies and then apply them consistently.
> observe the methods and principles in the Charity SORP.
22

make judgments and estimates that are reasonable and prudent.
prepare the financial statements on the going concern basis unless it is
inappropriate to presume that the charity will continue in business.
The Trusteès are responsible for keeping proper a￿OuntIng records which disclose with
reasonable accuracy at any time the financial position of the charity and to enable them to
ensure that the financial statements comply with the Charities Act 2011, the Charity
(Accounts and Reports) R8gulations 2008 and Ihe provisions of the constitution. They are
also responsible for safeguarding the asset5 of the charity and hence for laking reasonable
steps for the prevention and detection of fraud and other irregularities.
The Trustees present their report wlth tha financial statem8nts of th8 charity for th8 year
ending 5th April 2025. The Trustees have adopted the provisions of Accounting and
Reporting by Charities.. Statement of Recommended Practice applicable to charities
preparing their accounts in accordance with Ihe Financial Reporting Standard applicable
in the UK and Republic of Ireland (FRS 102).
Approved by order cf the Committee of Trustees on 8th September 2026 and signed on its
If by..
Mr. D Cain- Chair
Dat8 8th September 2026
CLINICAL SECTION
Patlent & Publlc Informatlon
The Pain Relief Foundation IPRFI supports those Ilvlng wlth chronlc paln by provldlng expert guidance
and resourc8s. Through our webslte and educational leaflets, we help individuals better understand their
condltlons and explore potentlal treatment options
Onllne Help and Advlce
Our website, www.pginreli8ffoundation.org.uk, Is a comprehenslv8 online resource for chronic pain
8uffereTS. It offeTS a wealth of information on varlous aspects of chronic pain, Includlng its ¢auses.
symptoms. and available trealmenls. The website also features an online help and advice service, which
allows users to submit their queries and receive expert guSdance from the PRF'S team of medical
prof8ssionals.
Informatlvo Leaflets
Beyond our online support servlces, the Pain Relief Foundation offers a comprehensive library of leatlets
covering various chronic pain conditions. These resources have helped thousands of patients better
understand their symptoms and treatment options. Each leafiet is regularly updated in line with Centre
for Health Information Quality guldellnes to ensure the content remains accurate and accessible. They
are available foi download on our website and are also distributed to GP practices.
CD'S
The Coping with Pain CD was one of the early self-help aids for chronic pain sufferers. Wrth an
introduction by Magnus Magnusson, it soon became part of the pain patient's medicine cupboard.
Each section ofthe CD has been specifically designed to focus the minds of pain sufferers on ways
of easing their pain through relaxation and gentle exercise. As many as 2 out of 3 people who have
23

used it report that they have been able to improve their quality of life and find that their chronic pain
problem is eased.
Over 65,000 copies of the Coping with Pain CD have now been distributed through a range of
outlets covering the medical field and the retail sector. Additional CD'S dealing with specific pain
conditions are al8D available and they include.. Coping with Headaches & Migraine, Feeling
Good, Coping with Back Pain and Relaxation and Coping with Anxiety. Each of the CDS
Gontains relaxation programmes that help so rnany sufferers to find relief.
PAIN RELIEF FOUNDATION INFORMATION SCIENCES RESEARCH CO-ORDINATION &
EDUCATION
Introductlon
Leveraging the 6xp8rtisè of pain clinicians, this dèpartment works In close alignment with the
Foundation Education Sub-committee. Our remit is to ensure the Foundation meets its educafjonal
obligatlons by managing all conferences, meetings, and training courses for healthcare professionals.
Additionally, the department provides administrative 8UPPOrt for these Iniliatlv8s and man8ges patient
and publi¢ information resource$, inclufjing a comprehensiv8 online portal dedicated to chronic pain
EDUCATION
Meetln
s and Coursgs
Meetings and courses which are developed and structured are aimed at all hèalth care professionals
with Ihe sole purpose being to educate participants 8bout all asp8Cts of chronic pain management.
Originally focused on a natlonal audlenc8, our programs have galned Internation81 recognltlon. now
attracting partlclpanls from a¢ross thè globe.
Foundation cour$es & lectures
Planning is well underway for our annua5 Cllnlcal Management of Chronlc Paln course.
Designed as 8 vibrant, hands-on clinical experience, this 2.5-day program is tailored for
Consultants, Specialist Registrars, Anaesthetists, Advanced Specialist Nurses, GPS, and
Physiotherapists with exisling experien￿ in pain management.
Thls yearfs ¢ourse is led by Dr. Hemkurnar Pusharaj and Dr. Manohar Sharma, both Specialists in
Pain Medicine at The Vvalton Centre NHS Foundation Trust, wilh expert support from Consultant
Cllnlcal Psychologist Dr. Kerry Matthews.
We are committed to continuous improvement,. we carefully review all participant feedback
annually to ensure our Curriculum remains at the forefront of the field. The course features a
dynamic blend of lectures, seminars, Clinical observations, theatre sessions, and grand rounds. A
highlight Dfthe program is a dedicated day wilhin The Walton Centre's Pain Management
Programme, where participants gain firsthand insight into multidisciplinary patient assessments
and evidence-based treatment pathways.
The Foundation continued in its role of facilitating the North England Pain Group (NEPG) one-day
meeting in Leeds. This year's programme was organised by Dr Karthik Dhandapani, Consultant in
Pain management at York Hospitals. The meeting covers many topical and highly relevant areas in
the current Practi￿ of Pain Medicine.
With organisation underway the 25th Pain Rellef Foundatlon Annual Lecture will take place in
October. This yearwill honour the late Felicia Cox, Nurse in Consultant Pain Managernent
24

The eulogy will be given by Dr Gill Chumbley, Registered Nurse and leading expert in pain
management. The Lecture will be delivered by Prof Candy Mccabe, Clinical Academi¢ Nurse,
University of the West of England,
The Foundation biannually hosts the EFIC Liverpool ￿￿ter Cancer Paln School, aimed at
educating young European doctors and allied health professionals in cancer pain management.
The next course, led by Dr. Manohar Sharma (Consultant in Pain MedicinelFoundalion Trustee),
wlll take place in October 2026. This 4-5 day intensive program focuses on evidence-based
assessment and treatment. Capacity is limited to 25 attendees.. 15 plaGes are EFIC-funded for
European dodors, with 10 spots reserved for intemational and UK-based delegates.
Further information regarding our education courses Is avall on our websit6 under the events
section
The Foundation Essa
Com
etition
The competition is run annually. The aim of thls ¢omp8tition is to raise awar@ness nationally
among medical undergraduates about chronic pain and the Pain Research Institute.
The competition 18 open to multiple dlscipline entries Medlcine and all health profession
Undergraduates including occupational therapists, physiotherapist, nurses, and psychologists.
The winning entries for 2025 are below..
Flntan Conwayi Unlverslty of Edlnburgh - Rethinking Pain." The Gut Mlcrobiome as a Novel
T8rget in Inflammatory Arthritis.
Vernon Fernande$, The London School of Medlclne and Dentl8try- Digital Twins & Artificial
Int811igance.' Red6lining Equilable ChroA7ic P81n Management.
samuel Brown, Unlverslty of Cambrldge - Thg 'Gut-Br8in-P8in Axls, In Chmni¢ Ivigraine.. rhe
Ther8p8Utic Role ofDiel and Probiotics.
Each winner received the winning prize of £500; their essays can be vlewed on our webslte.
Paln Relief Foundatlon Webslts
The Pain Relief Foundation websrte (www.painrelieffoundation.org.uk) is our primary
resource for evidence-based chronic pain information. We connect patients with expert-
vetted guidance, provide downloadable self-heSp resources, and publish regular insights
froni leading clinicians. In addition to our patient resources, our site serves as a vital
community hub for fundraising news and a professional portal for healthcare training and
events.
WORK & STUDY AREAS
The Institute continued to provide aGcommodation for research personnel to study their research
developments and prepare research reports and applications. The accommodation is fumished and
serviced, fully set out with computers workstations, and associated equipment.
25

RESEARCH
Below are a snapshot selection and brief description of research that is currently being undertaken
with the support ofthe Pain Relief Foundation. An in-depth progress report of the research can be
found on our website. www. painreleiffoundation.org.uk under the tab marked research.
Grant title: The Role of Glucagon-Like Peptide-1 In Migraine
Awarded to.. Dr Olivia Grech, University Birmingham.
Introduction
Migraine is a common neurologica￿ disorder affecting more than one billion people worldwide and
Is one of the leading causes of disability globally. Despite the development of newer migraine
trèatments, Many patients still do not achieve sufficient symptom relief. highlighting the need for
additional therapeutic approaches.
Migraine involves the activation of pain pathw8ys linked to the trigeminal system, which can lead
to headache pain, sensitivity to light and sound, and other neurological symptoms. During a
migraine attack, the Irigeminal neNes release proteins such as calcltonin gene-related peptide
(CGRP), which plays an important role in triggering and amplifying migraine pain.
Glucagon-like peptide-1 (GLP-11 is a naturally occurring hormone released after food intake that
helps regulate blood sugar levels and appetite. GLP-1 receptor agonists are now widely prescribed
for diabetes and obesity treatment. Interestingly, ernerging evidence has also suggested that th8se
drugs may have protective effects within the nervous system and could be beneficial in
neurological dlsorders.
We hypotheslsed that GLP-1 may be an effective therapy for migrain8 and it may act via altering
CGRP release.
Thé rlma
alms of thls work were:
1. a) Assess the effect of GLP-1R agonism on cllnlcally relevant phenotypes by maasuring
mechanical thresholds after acut8ly administering a migraine trigger.
bl Assess the effect of GLP-1R agonism on clinically relevant phenotypes by measurlng
mechanical thresholds after chronically administering g migralne trigger.
2. Assess the effect of GLP-1R agonism on processing pain signals related to headaches by
measuring neuron firing in the trigeminocervical complex (TCC}.
3. Determina th6 effects of GLP-1R agonlsm on CGRP expression.
To address these aims, we used cllnlcally relevant preclinical migraine modèls and combined
behavioural, electrophysiological, histological, ar)d biochemical approaches.
Results
GLP-1 and Mi
raine-Related H
ersensitivit
This funding enabled us to establish and apply preclinical models that capture key features of
migraine-relaled sensitivity. These approaGhes allowed us to assess sensory changes relevant to
headache and facial pain, including in models designed to reflect both short-temi and more
persistent migraine-like states. Using these models, we were able to explore whether GLP-1
receptor activation influences migraine-related hypersensitivity. The findings provide encouraging
preliminary evidence supporting further investigation of GLP-1 signalling in headache-related pain.
GLP-IR Activation and Mi
Taine-Related Neuronal Activi
26

The projert also supported studies examining migraine-related activity within brain regions involved
in pro￿sSing headache pain. This allowed us to investigate wh8th8r GLP-1 receptor activation can
influence central pain-signalling pathways relevant to migraine.
These experiments provided valuable mechanislic insight and helped strengthen our understanding
of how GLP-1 signalling rnay interact with neuronal pathways involved in migraine.
GLP-1R Activation and CGRP Si
nallin
As CGRP is a key molecule involved in migrainè biology, we investigated whether GLP-1 receptor
activation could Influen￿ CGRP-related signalling. The funding enabled us to assess this pathway
using both tissue-based and migraine-relevant experimental approaches.
This work generated preliminary evidence that GLP-1 signalling may interact with CGRP-related
mechanisms. Given the importance of CGRP in current migraine treatments, these findings support
further investigation into how GLP-1-based approaches may complement or inform existlng
therapeutic strategie5.
Overall, this project has provided an important platform for exploring GLP-1 receptor slgna15ing as a
novel pathway of interesl in migrain8 research. The funding enabled us to develop and apply
linically relevant preclinical models, generate preliminary mechanistic dala, and strengthen the
evidence base needed for future sludi8S.
Grant title; Biomarkers In Burnlng Mouth Syndromg,
Awardod to: Dr Franois O'N8iI, Universlty LIVe￿O01.
Back
round to
ro
ecL
The project's main aim is to test whether Corneal Confocal Microscopy ICCM) can be used as a
surrogate to tongue nerve fibre density in Burning Mouth Syndrome IBMS), Prior studies in the
literature have shown Ihat the density of small diameter neNe fibers is reduced in the tongue mucosa
of BMS patients. This is similar to that seen in skin biopsies of other small netve fi'bre neuropathy
conditions. Also, we recently showed that in a small pilot study that BMS demonstrated a reduction
in nerve fibre density as seen in the cornea of the eye by CCM. To allow CCM to be used as a new
non-invasive biomarker test in BMS patients we first have to show the amount of neNe fibre density
change seen in both tests are similar and can be diagnostically accurate.
To do this we are collecting tongue biopsy samples from patients with Burning Mouth Syndrome,
{invasive procedure} preparing these samplgs to look at under a microscope to counl the number
and density of nerve fibres in the surface lay8r of the tongue. Separately, we are performing Corneal
Confocal Microscopy, (non-invaslve procedure), in the same patients lo provide a count of nerve
fibres and density as seen on the surface of the eye. We then compare the data from both samples
lo see if they are in agreement. If so, this will allow CCM to be used to facilitate interrogation of the
hanges in netve fibres seen in this condition throughout the duration of the condition and during
potential treatments.
A further objective of the study is to examine whether immune colls are increased in this group of
patients. During the previous pilol study, we also showed that there was an increase in the number
of Langerhans cells present in the cornea of BMS patients. This number was up to 3 fold higher than
nomial. This has not been investigated in tongue biopsies and so together with the evaluation of
nerve fibre density in these samples being collected we are also looking at the presence and spatial
orientation of Langerhans Gells and their position relakn've to nerve fibres.
Pro
ect
ro
ress
Recruitment:
27

Target recruitment - 60 BMS patients and 20 healthy controls
Present recruitment numbers - 45 BMS patients and 18 healthy controls
Present recruitment numb?rs are good with the femaining participant numbers on targel for
r8cruitment in the present study timeframe.
Sample prooessing:
Samples from both BMS and healthy controls are presenlly being prepared for processing
with some optimisation of protocols for staining of nerve fibres and Langerhans cells on
biopsies.
CCM and Blink reflex testing:
Dr Jamie Burgess is being train8d up to do blink reflex testing and will then timetable patients lo
attend for CCM and blink reflex testing on the same visil. This is starting in June 2026.
El8ments of study still to complete:
A further 15 BMS patients and 2 healthy Gontrols to recruit and $8mples taken. ReGruitmènt is
actively Unde￿aY and a push is being made to complete this as soon as possible
Once 811 sarnples are prepared then proce8sing and slalning to be finallsed. Analysis of n8rve fibre
density of both biopsies and CCM data and comparison made
28

eTMR Limlled
Statutory Auditor
C•ntury Building$
14 St Marls Parsona9*
Manch88ler
M3 2DF

Report of the Independent Auditors to the TTUStees of
Pain Relief F?undation
Opinlon
We have audited the finan¢ial 51alements of Pain Relef Foundation Ith& 'charitable company'l for the year ended
S April 2026 which comprise the Statsmenl of Financial Activities, the Balance Sheet, th& Cash Flow Statement and notes
to the financial statement5, including a summary Df significant accounting pollcie$. The finan¢lal reportlng framework that
has been applied in their preparation is applicable law and Uniled Kingdom Accounting Standards (United Kingdom
Generally Accepted Accounting Practice).
In our opinion the financial 5tatemenls'.
- give atrue and fail view of the slate of the charltys affalrs as al 5 Apdl 2028 and of ils ir￿ming resources and application
of resources, including it8 income and expenditure, foi the year then ended..
have been properfy prep8r8d in aecordanc8 with Unit8d Kingdom Gènerally Accepted Accounllng Practice., and
have been prepared in ac¢ord8n¢¢ wllh th& requirements of the Charities Act 2011.
8a81$ for opinlon
We conducted our audit Èn 8eeordanc& with Internation85 Standards on Auditing IUKI IISAS IUKII and appllcable law. Our
re$pon5ibililiÉs undfrr those standards are further described in the Auditors, re8ponsibllilies for the èudlt ol Ihe financial
slalemenls se¢llon of our report. We are independent of the charitable cotnpany in Accordance with the ethical
iequlr¢menls that are relevant to our audil of the financial slalements in the UK, including the FRC'S Ethical Standard, and
we hav8 fulfillad our other ethical responsibililies in accordance wilh Ihesg reqU1￿Ments. We be15eve that Ihe audll
Évidènce we have obtained is sufficient and appropriate lo provide a ba¥ls for ouc opinion.
ConcluBlong rolatlng to golng concern
In auditing the financial staternenls, we have concluded that thè Iruslees, use of the going concem ba318 of 8ccounllng In
the prepaiation of the tlnanclal slalemonls 1$ approprlatg.
Based on th• work we hav¢ performed, we have not Identified any malerlal uncerta1nties relating to even18 or conditions
that, indlvidually or ¢olle¢tlvely, may cast Slgnificant doubl on the ch3rS18bl8 company's abilily lo continué a8 a going
concem for a p8rlod of 8t least tw•lve months from when the financlal 81alements are 8ulhorl$ed for issuè.
Our re$pon8ibllities end th¢ re$ponsibllltles ol the trustees with rèspect to golng concem ar8 d88crlbed In the relèvant
$ecllon$ of thls report.
Oth?r Informatlon
Thé Irust•ès ai8 r8spon55ble for Ihe other Informatlon. The other information ¢omprl8OS tha informalSon Included in Ihe
Annual Report, olhgrthan the financial slalements and our Report of the Indèp•nd8nt Audltors the￿on.
Our opinlon on thé financial statements does not cover the othèr informallon and, except lo the extent olhgrwl¥e explldtly
slated in our report. we do not express any lorm of 8ssurgn¢o ¢oncluslon thereon.
In connecllon with our audit of thè flnancl81 stalements, our responslbllily is to fead th& othgr Infomation And, In dolng so,
consider whether the other Informatlon Is materially inconsi8t8nt with the fin8nclal stat8ments or our knowledge oblain&d
In the audit or olherwise appears to be materially misslaled. Ifwe idÉntify such materlal Inconsistencies or appaignl material
misstatèments, we are required to determine whether this gives rfse lo a material misslalemenl in the financial statements
th•msèlv&s. If, based on the work we have performed, we conclude that there is a matsrial misslalemenl of Ihls other
inlormatlon, we are required to report that fact. We hav8 nolhin9 to report in this regard.
Matters on whlch we aro requlred to report by tx¢eptlon
Wè have nothing to report In respect of the followlng matlers where the Ch8ritles (Accounts and Reports) RegulatSons
2008 requlres us to report lo you if, iri our opinion..
the information given in the Report of ltte Trustee8 13 in¢onsistÈnt In any material Tespeei with the financS01 $tstements',
or
thè eh8dty has not kept adequate accountlng records., or
the financial statements are not in agreement with the accounting records and returns.. or
we have nol received all the infomialion and explanation8 we requir8 for our audit.
Rèsponslbllltles of trustees
As explained more fvlly in the Statement of Tru51ees' Responsibili11¢s, the trustees (who are also thè dirÈctors of the
charitable company for the purposes of company lawl are Tespon8ible for the preparation of the financtal $181emonts and
for ￿l￿g tsalisfied that they give a true and fair view, and for such intern81 control as the trustee5 delerniine is neceES&ry
to enable the prgparativn of financial statements that are free from material mis$l8lemenl. whether due to fraud or error.
In PTeparing thè financial statements. the trustees are r&sponsibleforassessing the charitable cotllpanvs ability to continue
8s a going concern, dlscloslng, as appllcable, matters related to going concem and using thè going cOn￿r￿ basis ol
accounting unless the trustees ¢ilh¢r intend lo liquidate the charitable company arto ceasè operalons, or have no realistic
allemativè bul to dts so.
30

Report of the Independent Auditors to the Trustees of
Pain Relief Foundation
Our re5ponsibilitTres for the audlt of the flnanelal ststements
We have been appointed as audilors under Sectson 144 of the Charities Act 2011 and report in &cordance wlh the Act
and relevant regulation3 made r)¥ having èff8et Ihèr8und8r.
OurobjÈctivès arèto obtain reasonable assurance aboutwhetherthe financial statements as a whole are freetrorn material
mis5tatgtn¢nl, whether due to fraud or error. and lo issue a Report of thè Independent Auditors that in¢ludèx our oplnion.
Reastsnable assurance is a high level of assurance, bul is not a gu8ranlèÈ thai an audit conducted in ac¢ord8n¢e with
ISAS {UKI will always detect a rnaterial rnis3talemenl when it exists. Mls8lalomenl8 can arise from fraud or orror and a
c0n8lde￿d material if, individually or in the aggregate, they could reason&bly be expected to influence the economic
dÉ¢i$ions of users taken on thè basis of th•sè finarti81 statèm8nts.
The extent to which our procedures are capablo of dele¢llng ImgularStles, InGludlng ffa(Kl Is detslled below..
Our approach lo identifying 8sJÈssing lh8 risks of matèrial misstatement in r&sp8Ct ol irr8gularitias. including fraud
and non-compliance with laws and regulations, w8$ as hllows..
. we identified the significant laws and regulations applicable lo the charlty whlch w8 ¢on8ldered could have a dlre¢t
material effect on the financial slalernenls or the operalions of the chaiily. Said 58ws and regulations include but 8r8 not
Ilmiled lo Ihe Charities Act 2011. t?￿atIon legislation and data protection, 8nli-brybery and employmènt lagislalion.,
the identified laws and regulations were communicated wilhln the audll team regularly and the learn remalned alert to
In81ances of non.cofflplianca Ihrou9houl the audll.
We assessed the s¢J8ceptibility of the charity'3 financial slalern8nls t# mat•ri81 mi8st3lèmÉnt, including obtaining an
understanding of how fraud might occur. We #180 addre88ed the risk of fraud through management bias and overrlde of
controls by.,
- updallng and reviewing our knowledge of the charity, Its Iru8lee8 ¥nd intèrnal fin8nclBI luncllon, lttg￿hèr with Ih8lr
systems and inlemal controls. This included maklng onqulrles of management as to Ihelr knoW￿dg￿ of aclual.
suspected and 8lleg8d fraud.. and
¢on8ldering the inlemal controls in place lo mlll9?lo ri$k$ of Iraud and non-compliance with laws gnd regulations.we
concluded that whllst the charity had eontrols in pl8c8 that werè approprlata to its siz& and the nature of tts acUvitie&, wè
could not rely on those 8y3lerns and internal ¢onlrols oxcluswely for the purposes of our audit work. We therefore adopted
a 8ub8tantive and transactional approach lo our audit, Seeking lo verlfy figures In the balance sheet lo Ihifé party evidence
and tran30￿1￿￿9 wllhln the Slalemenl of Finan￿81 Acllvilies lo external independent documentation.,
W8 did not r8view 8V8ry transactlon, However, we adopted an 8ppro8¢h b86ed on testing a Sample of Ir8ns8Ctlons. In
chooslng our samplo, wo le$ted transactions Ihat were material In nature and in addition a random sample of othgr
Iransacllon. By ¢hoo$lng transactions ol a material nature, our audit work18 de8igned lo detect rnaleri81 mi$8lalaments.
The use of random testing on other Iransadons Is designed to delecl other irregularitiès and the operallon of tho charlly'8
internal control systems generally. If exception5 were noted, our 8udll wort was expanded lo lesl mre tr8n$a¢llons wllh
a view to d8t6rmlnlng whether the exception was of an i501aled nature..
We porfomied analyllcal pro¢edure8 to identify any unusual or unexpected relationships.,
We tested journal entries lo identify unusual transactions and investigated the rationale behlnd slgnlficanl or unu$u81
transactions.
There are inherent limilallons In our audll procedures described above. The rnore removed that laws and regulations are
from financial Iransaclions, the less Ilkely il Is that we would become BwBre of non-compliance. Auditing standard5 also
limit the audit procedure3 re4uir¢d lo identify non-¢ornplionce with laws and regulations to enquiry of the Irustees and other
m8naoemenl and the in8pection of r8gulatory and leg81 corrèspondenc8, if any.
Molerlal mlsstsl¥monls Ihal orlse due lo fraud can be harder lo detect than those that arise from error as they may
involve d¢liberal8 concealment or collusion.
A further dèscripllon of our responslbS1rties for the audit of the financial slalements is located on the Financial R¢portin9
Councll's webslte at www.Irc.org.ukJaudrfLorsresponsibililies. This description forms part of our R8PQrt c)f th& Indep8ndenl
Auditors.
31

Report of the Independent Audttors to the Trn$tee$ of
Pain Relief Foundation
Use of our report
This report Is made solely lo tho ¢harStable companys Iru61ee8, as a body. in accordance with Part 4 of the Charities
(Accounts and Repgrtsl Regulations 2008. Our audit work has been undèrtaken so that we might slate lo the charitabl8
company's trustees those Tn8tter8 we are ieqtjired to stale to them in an audilors, report and for no other purpose. Tts tha
fullest extent permitt6d by law, w8 do not aceopt or assume responsibility to anyone olher than the ¢haritab1e company
and ihe charitable ￿MpanY'S trustees as a body, for our audrt work. for thls report, OT lor the oplnions we have formed.
BTMR Llmlled
Slatutory Auditor
Eligible to act as an auditor In lem$ of Sectlon 1212 of the Companiès Aet 2006
Century Bulldings
14 St Mary's P8rson8gè
Manchester
M3 2DF
32

PAIN RELIEF FOUNDATION
Statement of Flnancial Actlvitles
for the Year Ended 5 April 2026
5.4.28
Total
funds
5.4.25
Total
funds
Unr&striet8d
funds
Re$lricled
fijnd
Notes
INCOME AND ENDOWMENTS FROM
Donallcfis and legacies
137,483
137.484
116.590
Other trading activit188
Investrnenl in¢om&
29,984
103,706
61,798
91.782
103 706
45,186
Total
271 173
332.972
EXPENDITURE ON
Ralslng tund$
Other trading acliville8
Investrnonl man8gernenl co¥18
17,603
17,603
18,084
29,270
29,270
29,858
Charltable actlvlt5es
Research
Education
419,319
27,796
447,115
336.798
5,441
Total
452 847
480 643
372 097
Nel g8in3 on Investments
261,405
261,405
45,638
NET INCOMEflEXPENDITUREI
79,731
34,003
113.734
180,2251
RECONCILIATION OF FUNDS
Tolal lunds brought loNard
2.709,772
2,843
2.712.416
2,792,640
TOTAL FUNDS CARRIED FORWARD
2 789 S03
2 826,149
2712415
The notes form part of these finan¢i81 statements
33

PAIN RELIEF FOUNDATION
Balance Shè•t
S April 2026
5.4.26
Totsl
funds
5.4.25
Total
funds
Unrestricted
funds
Restricted
fund
Notes
FIXED ASSETS
Tangible assets
Investments
14
15
40,264
2 764.143
380
40,644
2,764,143
47,553
2,647,838
2.804,407
380
2.804,787
2.695.391
CURRENT ASSETS
Stocks
Deblors
Cash at bank and in hand
16
631
1,756
35.082
631
1,756
653
2.27S
37,469
40,266
77,735
60,515
CREDITORS
Amounts falling due within one year
18
152,3731
14.0001
156.3731
143,4911
NET CURRENT ASSETS
149041
21,382
17,024
TOTAL ASSETS LESS CURRENT LIABILITIES
2,789,503
36,646
2,826,149
2,712.415
NET ASSETS
2 789,S03
2 828 149
2 712415
FUNDS
Unreslrlcted funds:
General fund
Designated unre8lrlcled
16641
2 790 067
35.142
2 674 630
2 789 503
2 709 772
Reslrlcled funds..
R¢strieted fund
TOTAL FUNDS
2 826 149
2 712,415
These financial slalements have been 8uLliled under the requiremants of Section 145 of the Charllle$ Act 2011.
The finBncSal slalement5 were approved by the Board of Trustees and authorlsed for Issue on..
and were slgned on its behalf by..
Chairman- Trustee
The notes form part of these finan041 ¥latements
34

PAIN RELIEF FOUNDAMON
Cash Flow Statgment
fortFiè Year Ended 5 April 2026
5.4.26
5.4.25
Nol&s
Cash flows from operating actlvltle
Cash g8neraled from operations
Finance costs paid
Tax paid
1231,2781
1226}
460
1230,8311
12971
472
Net cash used in operating activikneB
231.0441
231.6001
Cash flows fram Inve6tlng actly1￿e8
Purchase of tangible fixed assets
Purchase of fixed asset inve3trnenl¥
Sale of fLxed 81sè1 invèstmènts
Interest ro¢eived
Dividends r¢¢elved
{1,9631
161.2891
228,382
1269,1121
414,212
103 898
N$1 cash provided by inv•stlng actlvlti8s
248 806
249 088
Chang• In ¢a$h and Cash •qulval•nts In
the reporting pgrlod
C¥8h and cash equlvalents at the
bvginnlng of the reporting period
17,762
17.988
Cash and eA•h equlvalonts at the end of
the reportlng perfod
The notes form part ofthese financAal stalements
35

PAIN RELIEF FOUNDATION
Notes to the Cash Flow Statement
for the Year Ended S April 2026
RECONCILIATION OF NET INCOMEIIEXPENDITUREI TO NET CASH FLOW FROM OPERATING
ACTIVITIES
6.4.26
5.4.25
Net lrt¢omell•xpèndltLtr*l lor th* r•portlng p•rlod las per the
Statement L)f Flnanclal Actlvltie51
Adjustments for-
Depreciation chargès
Gain on investments
Interest received
Finance ¢9518
Dividend8 received
Decrease in stocks
Decrea$ellin¢reasel In debtors
Increas¢1ld¢Giea8el In Gredltors
113,734
(80,2251
8.909
1261,4051
8,123
145,6381
1101
297
184,448)
226
{103,69BI
22
60
12.8B2
28,828
Net ca$h u$•d in op?Yali¢n$
231 2781
30,8311
ANALYSIS OF CHANGES IN NET FUNDS
At 6.4.25
Cash fflow
At 5.4.26
N•t ca8h
Cash al bank and In hand
Total
The notes form part of these financial statements
3e

PAIN RELIEF FOUNDATION
Notes to the Flnanclal Statements
for the Year Ended 5 April 2026
DESIGNATED FUND
The designated fund repro$ènls ÈLJMS set asidé. o(rt of unr8Strict8d funds. to meet the ongoin9 Costs of the chair
of Professor of Pain,
2026
2025
Investment income..
Interest receNtd
Dividends
Realised galns on Investments sold
Unr88lised g8ln on revaluing investm&nts to marf(el value
Total designated inGome
Less..
Realised loss on sale of investments
Unrealised profiV{lossl on revaluing inve51menls to nlathet value
5.665
98,033
154,488
4,036
60,412
71,207
258,186
155,655
106,917
111,6661
125,5691
111,7941
Expenditure out of designated funds
Transfer of nel expenditure to General Fund
OOD
Net designat?d (ex￿ndItuT$)lln¢Om•
IIIS,4371
1103,7081
ACCOUNTING POLICIES
Bag18 of preparlng tho finan¢lal $tatem*nts
The financial slalemenls of the ch3rily, which Is a publlc benefit enllly under FRS102, hav& be?n p￿pared in
accordance with the Charill88 SORP IFRS 1021 'Accounllng and Rèportlng by Charillas,. Statement of
Recommended Practic# appllcabl& lo charllles proparSng their accounts In a¢¢ordance wllh the Financial Reporting
Standard applicable In the UK and Republic ol I￿land IFRS 1021 leffe¢llve 1 Jonuary 20191,, and the Charitles Act
2011, The financlal 8talernen18 havo bg&n preparèd undèr th¥ hlslo(1¢81 cost convanlion with thè exception of
Investments which are Included al rnarkel value.
Income
All income is recognised in the Slalemenl of Flnan¢lal Aclivltles once th& charity hos onlill&menl to the fund$ and
51 is probable that the incom8 will be received and the amount can b? measured reliably. Th8 charlly'3 incomé 1$
made up of gSfts. donatlon8, legacles, fundraislng, spon8or8hip and Investment Income.
Expendlture
Llabilities are recogni8ed as expenditure as Boon aB Ih¢ro 1$ a legal orconBlruclNe obllg?lion committing the charfly
to that expenditure, it is probable that a Iransler of ècontsmlc benèfits will bÈ rèquired in sèttlèmènt and the amount
of the obligation can be mea$ured reliably. Exp$ndllur¢ Is a¢¢ounl¥d for on an a¢cruals ba$ls and has been
cla$8ifiod und¢r headings Ihol aggrggal¢ all costs related lo the category. Where costs cannot be directly attributed
lo particular hgadings they h8v8 boèn allocated to Activitiès on a bagis consistant with the use of rèsources.
Grants offered $ublecl lo ¢ondltlon$, such a$ duration of the grant, whlGh have nol been met al the year end date
are noted as a commitment but not accrued a5 expenditure.
Allocatlon and apportlonment of costs
Certain expenditure is diredly attributable to SFAcific ￿tIVitIeS and ha8 been included in Ih08e c08t categorie$.
Certain olhercosls, which are alliibutable to more than ong aclivily, are apportionèd acrtsss categories on thé basls
of an estimate of the proportion of lime spent by staff on those aclivilies.
Tanglblè flxed ass•ts
Depie¢iatlgn Is provlded at the following annual rates in order lo write off each asset over its estimated useful life.
Long leasehold
Plant and machinery
Over the period of the lease
25°/ll on reducing balance and 150/ts on Cost
Fixtures and ffittings
25Yll on cost
Expenditure on indNidual assets which is les5 than £500 is not caw'talised.
37
continued...

PAIN RELIEF FOUNDATION
Notes to the Financlal StateTnents-continued
for the Year Ended 5 April 2026
ACCOUNTING POLICIES- contlnued
Stocks
Stocks art valued at th¢ lower of ¢osl artd nel reallsable value. after maklng due allowance for obsolete and slow
moving ileffl8.
TAxation
The ch8ri1y is exempl from corporalSon lax on Ils charflable acllvllles.
Fund accountlng
UnreStr￿ted funds can be used in accordance wilh the charitable obj8clive8 Èt thè distrÈtion ef tha tnjstees.
Restriet&d funds can only b@ used for particular restricted purposes within thè obje¢ts of thè ¢harily. Re$trl¢llons
arf$e when spe¢Med by Ihe donor or when funds are raised for particular reslrlcled purposes.
De$lgnated fund
The Designated fund represents the investment and i¢1o18d Incomè whSch th8 truslees have designated lo be used
spe¢ifLcally far funding th8 ehsir of thè Piof&s8or of Pain.
Rostrl¢ted fund
Thè Restrict8d fund represents the income which was made availablè for the purposes of acquirfng a Transcranial
Magnetic Scanner and sponsorships received. The related expendlluw ropre5enl monèy spent in relation to
re$trS¢t¢d Income.
Penslon cost8 and other pogt.retlrement beneflts
Thè charity operalèB a defined contribution pen81on $chem8. Conlflbutlons payable to the charily'8 pension
Scheme are charged lo the Statement ol Finart¢lal Acllvlties in the perfod to which they relate.
Flnanclal Instruments
Finan¢i81 instruments are c18sslfflod and accounted for a￿OrdIng to the substance of the contractual arrangem8nl.
as gilhgr finan¢io18¥3g1¥, ffinanclal liabilities or èqulty Inslruments. An equlty in8lrumenl is any contract that
evlden¢e8 8 resSdu¥l interest in th8 a88els of the Chority after deductlnq all ot ils Ildbilitle8.
Investmonts
Inv$¥tmonl$ ar9 madg by the trustaes Bdlng through and on advice of professional Inve8lmenl managers. The
Investment 8lrategy focu3es on low lo mÈdlum rlsk inv8Stmenl5.
Investment 9oln$ and IM$e•
Gains and Ios5e8 whiGh aris? on the 8018 of invastmenis during th& year are termed "Realised galns and losses"
Those gains and 105ses that 8riso from U)è disclosure of inveslments at market value as at 5th Aprll each ygar are
lerrnèd'unreallsed galns and losses
GovernAnee costs
Govèm3nc• eosls rèlate to th8 gen8ral runnSng of the charity, as opposed lo fundr81$lng or ¢harltable aclivilie6
oxpenditure. They Include aud￿ and legal fees. accountancy and related support costs.
Costs of gonerating funds
The costs of fundraising event5 include the ¢osls Incurred by lh& Chatlty in a￿angIng golf days, appèals 8nd
sponsorships and are included in the SOFA on an accruals bas15.
Charltable activltles- Grant5 payable
Expenditure on charitable activities includes grants payable lo individu81s lo conduct reseorch Into paln. its cause8
and relief. and to disseminate research information logetherwilh related dir¢¢t ¢o$ts and support costs, all of which
are accounted lor on an accruals basis.
38
continuèd...

PAIN RELIEF FOUNDATION
Notes to the Financial Statements - ¢on¥nu8d
for the Y•ar Ended S April 2026
DONATIONS AND LEGACIES
&4.26
5.4.25
Gifts
Gift alded donalons
rax recoveiEd on glft aided donations
Legacies
Sundry income
38,912
3,111
14601
95,886
35
65,259
4,951
1,245
44,938
197
116.590
OTHER TRADING ACTIVITIES
5.4.26
5.4.25
Fundr8ising events
Sponsorships
Mgeting fees
Le￿$ Codavef
4,297
7,225
18,462
1,205
5,535
26,440
91,782
INVESTMENT INCOME
5.4.26
5.4.25
LS3led Investments
Dep¢sit &¢ceunt Inlere$t
103,698
84,448
103706
OTHER TRADING ACTIVITIES
5.4.26
5.4.25
Staff cwts
INVESTMENT MANAGEMENT COSTS
S.Q26
5.4.25
Portfollo management
11,667
CHARITABLE ACTIVITIES COSTS
Grant
fvnding of
Support
costs Ise8
note 101
Direct
C081s
(sèÈ notè
91
Tot813
Research
Educatlon
107,825
58
273,690
6S,600
447.115
107.883
273 690
39
conlinued...

PAIN RELIEF FOUNDATION
Notès to the Financial Statements- contlnued
for the Year Ended 5 Apill 2026
GRANTS PAYABLE
5.4.26
5.4.25
Research
273,690
184,381
10.
SUPPORT COSTS
Information
technology
Governance
cos18
Management
Flnance
Totals
Reseorch
Education
29,209
115
5,376
30,900
65,600
115
5,376
11.
NET INCOMEIIEXPENDITUREI
Nel Incornellexpendllurel13 8tsted after chargingllcr8dillngl..
5.4.26
5.4.25
Audlloys, remunerallon
Audllor$' remuneratlon for non audll work
Depredatlon- owned assets
5,000
3,340
5,ODO
3.340
12.
TRUSTEES, REMUNERATION AND BENEFITS
No tru$loes' rgmuneralion or othgr beneffits were paid for the year ended 6 Aprfl 202S nor for Ihe yearended S Aprfl
2025.
Tru$t•¢S' gxpgn$o•
There were no Iru8tees' expen8e8 pald k)r the year ended 5 Apfil 2026 nor for the year ended S Aprll 2025.
13.
STAFF COSTS
The aver8ge numb$r of &mployees for the year wa$ 412024.. 41.
14.
TANGIBLE FIXED ASSETS
Flxlures
and
fitting8
Long
leasehold
Plant and
machinery
Tot81¥
COST
At 6 April 2025 and 5 April 2026
114 302
204 403
326 983
64S 688
DEPRECIATION
At 6 April 2025
Charge for year
81.319
3,266
192,604
2,950
324,212
693
598.135
Al 5 Aprtl 2026
195,554
324 905
605 044
NET BOOK VALUE
At 5 April 2026
29,717
8,849
2,078
40,644
At S April 2025
32,983
11,799
2.771
40
continued..

PAIN RELIEF FOUNDATION
Notes to the Financial Statements . ¢ontlnued
for thè Y•ar Ended S April 2026
15.
FIXED ASSET INVESTMENTS
Listed
investments
MARKET VALue
At 6 ApTiI 2025
Additions 01 ¢osl
Disposals at book cost
Revalualiong
2,647,838
269,112
12S9,7241
106 917
At 5 Aprll 2028
2 764.143
NET BOOK VALUE
At S April 2026
2,764,143
At 5 Aprll 2025
2,647,838
OversBa8 investment a68ets amounted lo £674,62512025'. £731,204).
Cosl gr valuation al S Aprll 202618 repr88entod by..
Llstsd
Inv*stThènt•
Valuation In 202$
Valuation In 2026
Cost
125,6691
106,917
2 682 796
2 764 143
16,
STOCKS
5,4.26
5 4.25
Finished good$
631
853
17.
DEBTORS.. AMOUNTS FALLING DUE WITHIN ONEYEAR
5,4.26
5.4.25
Tax
Prepaymenls and awwed In¢ome
778
97B
1,238
1.756
2,276
41
)ntIn￿d...

PAIN RELIEF FOUNDATION
Notes to th• Finan¢lal Statements - contlnued
for the Year Ended S April 2026
18.
CREDITORS.. AMOUNTS FALLING DUE WITHIN ONE YEAR
5.4.26
5.4.25
Accrua15 and deferred income
43,491
19.
MOVENENT IN FUNDS
Nel
Transfers
behveen
fund5
movemant
in funds
Al
5.4.28
At 6.4.25
Unrestrictèd fund8
Genèral fund
Design8ted unrèstdcted
35,142
2 674 630
1273,7061
3S3.437
238,000
238,0001
15641
2 790 067
2.709,772
79,731
2.789,503
Restricted fund8
Reslricled fund
2,643
34,003
38,646
TOTAL FUNDS
271241S
113734
2 826 149
Nel movemonl In funds, Included In the above are 0$ follow8..
Incoming
resource
Resources
èxpended
Ga1ns and
losses
Movement
in funds
UnreBtrfcted fund$
General fvnd
Designated unra8lricted
167,474
103 899
1441,1801
11 6671
1273,7061
353 437
261 405
271,173
1452,8471
281,405
79,731
ReBtrlcted fund•
Re8lrScled fund
61,799
127,7981
34,003
TOTAL FUNDS
332 972
480 6431
261405
113734
Comparatlv•g for movem•nt In funds
Net
movement
in funds
Transfers
b¢¢wean
funds
Al
5.4.25
Al 6.4.24
Unrestrlcted funds
2,790,162
180,390)
2.709,772
Restrictgd fund
Reslricled ILJnd
2,478
165
2,643
TOTAL FUNDS
2,792.e40
80,2251
2,712,415
42
continued...

PAIN RELIEF FOUNDATION
Notes to the Flnancial Statements - continuod
for thè Year Ended S April 2026
19.
MOVEMENT IN FUNDS- contlnued
ComparatNe nel movement in funds Included In Ihe above are as follows..
Incotning
r8souiee$
Re5ourc¢s
expèndèd
Gains and
Ioss8S
Oven￿￿1
in funds
Urtrestrlcted funds
234.228
1360,2561
45,638
180,3901
Reytrlcted fund
Restricted fund
12,008
{11,841}
165
TOTAL FUNDS
24e.234
372,0971
45.e38
80.2251
A current year 12 months and prlor year 12 months comblned pogillon 1$ 0$ fc41ow8'.
Nel
movement
In fund$
Transfers
betr4een
funds
At
5.4.28
At8.4.24
Unr88tricted fund¥
2,790.162
16S91
2,789.503
Restrlcted fund
R*8lrl¢t8d fund
2,478
34.168
38,648
TOTAL FUNDS
2 792 640
2 826 149
Net movgrnenl In funils Included In the above aro 05 follows..
Incomlng
resources
Rosources
expended
Galn8 and
lo$$es
Moverronl
In funds
Unreslrl¢l?d funds
505,401
1813,103}
307,043
18591
Ro8trlcted fund
Restricted fund
73,805
{39,6371
34,168
TOTAL FUNDS
852 7401
33 509
20.
RELATED PARTY DISCLOSURES
Th8r8 w8r• no r&l8tèd p8rty transactlons for the year ended S Aprll 2028.
21.
FINANCIAL COMMITMENTS
During the year grants payable lo researchers were approved in the total amount of £791,415 of which £564,407
remains payable in respect of fuEure periods.
43

PAIN RELIEF FOUNDATION
Detailed Statemènt of Financial A¢tlvltSos
for the Year Endgd 5 April 2026
5.4.26
5.4.25
INCOME AND ENDOWMENTS
Donations and19ga¢le¥
Glfts
Gilt aided don81ions
Tax recovered on glft alded donatlon8
Legacies
Sundry income
38.912
3,111
14601
95,886
35
65.259
4.951
1.245
44,938
197
137.484
116.590
Other trading activiti•$
Fundraising events
Sponsorships
Meeting fees
Leeds Cadaver
4,297
7,225
18,462
61.798
1,205
5,535
26,440
12.006
91.782
46,186
Investment Ineom•
Listed invÈ8tmÈnls
Deposit occount Inlern8t
103,698
84,448
10
103,708
TolaS Incomlng r•$our¢s$
332,972
246.234
EXPENDITURE
Othgr tradlng Actlyltltrs
Waggs
Social sacurily
P&n$lon¥
17,128
254
221
17,272
585
207
17,603
18.064
Investment management co¥ts
Portfollo management
11.667
11.794
Charltable a¢￿VI￿
Wages
Social security
Pensions
V8nu& & meeung costs
Sundry
Leeds Cadaver
DoproGialion of tangibl& ffixgd assets
Grants lo indlviduals
54,068
1,118
2,207
15,488
424
27,669
6,909
273,690
55,351
1,986
2.083
11,812
285
10,198
8.123
184,381
381,sn
274,199
Support costs
Management
Rates and water
Carried forward
18,836
18,836
18.427
18,427
This page does not form part of the stafvtory financial statements

PAIN RELIEF FOUNDATION
Detailod Statèment of Financial Actlvltles
for the Year End¢d S April 2026
5.4.26
5.4_25
Management
BroughtfoW￿l
Insurance
Telephone
Postagè and st8tion8ry
Advertising
Sundries
Computer soflware
Credit card chBrges
18,836
3,756
380
2,917
4,548
918
1,82a
226
18,427
3,546
753
2,308
4,442
1,457
1,765
297
33,409
32,9
Flnance
Bank charges
115
192
Infomiation t&¢hnology
Repalr5 and ienewals
5,376
5,214
Gov•man¢o cost8
Wage$
social security
Pen8lDns
Auditor$' remunerallon
Auditors, ramuner81ion for non audit work
21,207
472
881
5,000
19,850
612
837
5.000
3,340
Total r¢8our¢&$ expended
480 643
372 097
Ngt •xpenditure bof¢ro g•ln$ #nd lo$$¥$
1147,6711
(125,8831
Roall8•d rg¢ognls•d g8ln8 and lo•s
Not inv#8lmènl gainsl Iltsssesl
154488
Nèt In¢om?11gxpendltur?I
54,658
This pagè doès not form part of the statutory finan¢ial statements
45

Paln Ralief Foundation